Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             621 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormalities in miRNAome contribute to epithelial–mesenchymal transition of breast cancer cells Halytskiy, V.
2017
72 S1 p. S24
artikel
2 Access to innovative cancer drugs: Divergent outcomes of HTA bodies’ appraisals in France, Germany and the United Kingdom impact on the availability of new medicines Hartmann, M.
2017
72 S1 p. S115
artikel
3 Accuracy of ultrasound scan guided node biopsy in pre-operative diagnosis of metastatic axillary lymphadenopathy in breast cancer El Gammal, M.
2017
72 S1 p. S21-S22
artikel
4 A comparative analysis of orphan designations for rare neoplastic disorders versus other rare indications Pauwels, K.
2017
72 S1 p. S115-S116
artikel
5 Acute oncology education: developing a pedagogy with stakeholders using online learning to enhance learning, clinical practice and patient care Taylor, A.
2017
72 S1 p. S131
artikel
6 Acute toxicity of the bowel after stereotactic radiotherapy for abdominopelvic oligometastases Frelinghuysen, M.
2017
72 S1 p. S81
artikel
7 Addressing intraoperative adhesions, heat dissipation and uneven distribution of the perfusion fluid during HIPEC: The laparoscopy-enhanced HIPEC technique Lotti, M.
2017
72 S1 p. S59
artikel
8 A decade of screening: development of BreastCheck, the National Breast Screening Programme in Ireland prior to EUREF accreditation in 2015 Mooney, T.
2017
72 S1 p. S8
artikel
9 A decision aid for curatively treated breast cancer patients to effectively individualize the aftercare, improve shared decision making, and reduce costs Klaassen, L.
2017
72 S1 p. S22
artikel
10 Adherence to cancer treatment guidelines: influence of general and cancer-specific guideline characteristics Heins, M.
2017
72 S1 p. S115
artikel
11 Adjuvant breast cancer treatments affect homoarginine levels Aula, H.
2017
72 S1 p. S13
artikel
12 Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer Boku, N.
2017
72 S1 p. S77
artikel
13 Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas Cortesi, A.
2017
72 S1 p. S154
artikel
14 Adjvant HIPEC in gastric cancer patients with high risk of peritoneal carcinomatosis Aladashvili, A.
2017
72 S1 p. S73
artikel
15 Advanced breast cancer; clinico-pathological data and predictors of estrogen receptor positivity prior to biopsy, National Cancer Institute (NCI) pooled data experience Abou El-Kasem, F.
2017
72 S1 p. S19
artikel
16 Adverse health outcomes (AHOs) in childhood lymphoma survivors (CLSs): relation to self-reported general health Fossa, S.D.
2017
72 S1 p. S142
artikel
17 Afatinib vs gefitinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC: overall survival (OS) data from LUX-Lung 7 (LL7) Hirsh, V.
2017
72 S1 p. S184
artikel
18 A general model for cancer centers to conduct health technology assessments; a practical case of next generation sequencing in oncology Retel, V.
2017
72 S1 p. S118
artikel
19 A method for identification of tumor cells in the caval bloodstream in colorectal cancer with liver damage Ishchenko, R.
2017
72 S1 p. S60
artikel
20 5-Aminolevulinic acid-mediated fluorescence in colon cancer surgery: a histopathological analysis of fluorescent and non-fluorescent tumours Goldsworthy, M.
2017
72 S1 p. S61
artikel
21 Analysis of clinical and research implications of updating next-generation sequencing (NGS) libraries in the treatment options of lung cancer in a large cancer center Gonzalez Velez, M.
2017
72 S1 p. S186
artikel
22 Analysis of expression of microRNA in cytological smears as a new method for the diagnosis and prognosis of preinvasive cervical carcinoma Bakhidze, E.
2017
72 S1 p. S91-S92
artikel
23 Analysis of factors affecting survival in patients with lung metastases from colorectal cancer who underwent VATS-assisted surgical excision Lumachi, F.
2017
72 S1 p. S62
artikel
24 Analysis of prostaglandin-endoperoxide synthase (PTGS)-2 gene polymorphisms and risk of cervical cancer in an east Indian population: a case control study Sur, D.
2017
72 S1 p. S91
artikel
25 An easy-to-use prognostic model for survival in patients with cancer and symptomatic metastases of the long bones Willeumier, J.
2017
72 S1 p. S159-S160
artikel
26 A new effective enhanced recovery pathway after liver surgery using the LiMAx test − results from a multicenter prospective randomized controlled trial Lock, J.F.
2017
72 S1 p. S65-S66
artikel
27 A novel approach to locally advanced technically inoperable oral squamous cell cancers using neoadjuvant radiochemotherapy: results from a tertiary cancer centre of India Pawar, S.S.
2017
72 S1 p. S106-S107
artikel
28 Anti-cancer effect of Toxoplasma gondii-derived protein, profilin-like protein as a TLR agonist Shin, E.H.
2017
72 S1 p. S98
artikel
29 Antitumor activity of ipilimumab after pembrolizumab in patients with advanced melanoma in KEYNOTE-006 Long, G.V.
2017
72 S1 p. S128-S129
artikel
30 A nursing intervention to support cancer patients in dealing with chemotherapy-related symptoms at home (CHEMO-SUPPORT): a qualitative study of the patient experience Coolbrandt, A.
2017
72 S1 p. S166
artikel
31 A pharmacokinetics and pharmacodynamics equivalence trial of proposed pegfilgrastim biosimilar, MYL-1401H vs EU-Neulasta® and US-Neulasta® Waller, C.
2017
72 S1 p. S41
artikel
32 A pharmacokinetics (PK) bioequivalence trial of proposed trastuzumab biosimilar, Myl-1401O (A) vs EU-Herceptin (B) and US-Herceptin (C) Waller, C.
2017
72 S1 p. S40-S41
artikel
33 A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study Ross, P.J.
2017
72 S1 p. S69-S70
artikel
34 A phenomenology on the use of energy healing among Filipino cancer patients Alarilla, M.V.
2017
72 S1 p. S165-S166
artikel
35 A population-based study on temporal trends of five-year survival of patients with colon cancer by age group and gender in Bulgaria Tashkova, D.
2017
72 S1 p. S173-S174
artikel
36 A possibility for therapy of metastatic cutaneous melanoma with cationic peptides Lushnikova, A.
2017
72 S1 p. S127-S128
artikel
37 Approaches for optimal choice in treatment of gastric cancer with liver metastases Djuraev, F.
2017
72 S1 p. S74
artikel
38 A preclinical evaluation of niraparib efficacy as monotherapy, maintenance and after olaparib treatment (PARP inhibitor after PARP inhibitor) in patient-derived ovarian xenograft tumor models Mikule, K.
2017
72 S1 p. S96
artikel
39 A prospective study on quality of life among persons with lung cancer, before and after the chemotherapy treatment – evidence from South India Katpattil, S.
2017
72 S1 p. S164
artikel
40 A randomized controlled lifestyle intervention in BRCA mutation carriers Pasanisi, P.
2017
72 S1 p. S11
artikel
41 Are community detected cancers more biologically similar to screen detected or interval breast cancers and how is this reflected in survival? Elder, K.
2017
72 S1 p. S23-S24
artikel
42 Are cutaneous melanoma treatment guidelines keeping pace with rapidly evolving melanoma treatment options? A review of metastatic melanoma at a supra-regional service Henton, J.
2017
72 S1 p. S124-S125
artikel
43 A retrospective study of cancer testis antigens MAGE-A1 and MAGE-A4 expression in high grade endometrial cancer Juretic, A.
2017
72 S1 p. S88
artikel
44 A SNP genotype in the TGFBR1 gene is associated with earlier onset of colorectal cancer in males Mahon, G.
2017
72 S1 p. S58
artikel
45 Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles Nandunga, J.
2017
72 S1 p. S25-S26
artikel
46 Assessing the proportion and clinicoradiological profile of gall bladder carcinoma diagnosed in routine histopathological examinations of post cholecystectomy gall bladder (GB) specimen operated for benign GB disease Verma, N.
2017
72 S1 p. S79-S80
artikel
47 Assessing the quality of life of breast cancer patients undergoing treatment at the National Radiotherapy Center, Accra, Ghana Adusei-Poku, P.
2017
72 S1 p. S163
artikel
48 Assessment of BCR-ABL1 transcript levels at 3 months is the major determinant for outcome in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors Katalinic, D.
2017
72 S1 p. S100
artikel
49 Assessment of EpCAM intensity of expression and outcome in breast carcinoma neoadjuvant chemotherapy treated patients Shalaby, A.
2017
72 S1 p. S37
artikel
50 A study of lymphangiogenesis and vascularity in triple negative breast cancer patients in India Srivastava, V.
2017
72 S1 p. S22-S23
artikel
51 A study of the factors predicting radiation exposure to contacts of Saudi patients treated with low dose radioactive iodine (I-131) Salman, K.A.
2017
72 S1 p. S135
artikel
52 Asymptomatic versus symptomatic pulmonary embolism in oncologic patients: Does clinical presentation influence outcome? Piacentini, G.
2017
72 S1 p. S140
artikel
53 A tailored multidisciplinary head and neck cancer rehabilitation program compared to usual supportive care for patients treated with concomitant chemoradiotherapy: The design of an “assessment of effectiveness and cost-effectiveness in a multicenter prospective observational study” Beck, A.
2017
72 S1 p. S101
artikel
54 ATP promotes immunosuppressive MSCs inhibiting lymphocyte proliferation and expressing indoleamine dioxygenase Lotfi, R.
2017
72 S1 p. S98
artikel
55 Attitudes and beliefs of breast cancer patients toward their disease in urban South Africa: a cross-sectional descriptive study Rayne, S.
2017
72 S1 p. S34
artikel
56 Audit on cavity margins for breast conserving surgery at a District General Hospital Abbas, A.
2017
72 S1 p. S31-S32
artikel
57 Author Index 2017
72 S1 p. S199-S216
artikel
58 Awareness campaign about the irrational use of medicinal plants during cancer treatment Houda, A.
2017
72 S1 p. S132-S133
artikel
59 Baseline characteristics of responders and nonresponders from the phase 3 study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT) Reuter, C.
2017
72 S1 p. S112-S113
artikel
60 Beyond aspirin and metformin: The untapped potential of drug repurposing in oncology Bouche, G.
2017
72 S1 p. S121-S122
artikel
61 Biological features of triple negative BRCA-related breast cancer Botiralieva, G.
2017
72 S1 p. S14
artikel
62 BRCA1/2 mutation in breast cancer: biological aspects, patterns of care and impact on outcome in a monoinstitutional cohort Loi, M.
2017
72 S1 p. S19
artikel
63 BRCA 1 status and its association with family history Fatima, A.
2017
72 S1 p. S10
artikel
64 Breast cancer in young women in Algeria Caid, N.
2017
72 S1 p. S32
artikel
65 Breast cancer subtypes in an oncology centre in Nigeria: a retrospective review of 240 cases from Lagos Alabi, A.
2017
72 S1 p. S18-S19
artikel
66 Breast conservation surgery without frozen section study control for intra operative margin status – a prospective study Mohammed Ilyas, M.I.
2017
72 S1 p. S32
artikel
67 Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients Lagendijk, M.
2017
72 S1 p. S2-S3
artikel
68 Breast irradiation using personalised thermoplastic mask for immobilisation: Pros and cons Dinu, A.
2017
72 S1 p. S28
artikel
69 Breast magnetic resonance imaging (MRI) for local ductal carcinoma in-situ (DCIS) staging: Multicentric randomized controlled trial to assess the efficacy and cost-effectiveness of preoperative MRI to optimize breast surgery Balleyguier, C.
2017
72 S1 p. S36
artikel
70 Breast reconstruction using modified inferior dermal flap, implant, and nipple areola complex repositioning technique. Experience at MISR Cancer Center Amira, G.
2017
72 S1 p. S36
artikel
71 Breath volatile organic compound analysis for the diagnosis of oesophago-gastric cancer; multi-centre blinded validation clinical trial Markar, S.
2017
72 S1 p. S3-S4
artikel
72 Budgetary impact of lipegfilgrastim to the Mexican healthcare system Szende, A.
2017
72 S1 p. S118
artikel
73 Burden of chemotherapy induced febrile neutropenia in paediatric oncology in developing countries: the Children's Hospital Lahore Pakistan experience Ahmad, A.
2017
72 S1 p. S147
artikel
74 Burden of early and advanced breast cancer in the Netherlands Vondeling, G.
2017
72 S1 p. S15
artikel
75 Burkitt lymphoma in Northern Tunisia: Incidence, trend and projection Ben Khadhra, H.
2017
72 S1 p. S140-S141
artikel
76 Ca125 and hTERT in ovarian carcinoma: mutual modulation and implication of EGFR/PI3K/Akt/mTOR signaling pathway Antoun, S.
2017
72 S1 p. S88-S89
artikel
77 Can biosimilar products enhance resources utilization and quality of services for cancer treatment? Abotaleb, A.
2017
72 S1 p. S116
artikel
78 Cancer incidence in Colombia acquired immunodeficiency syndrome Pulido, D.
2017
72 S1 p. S141-S142
artikel
79 Cancer in the elderly in Northern Tunisia: Incidence and trends Ben Khadhra, H.
2017
72 S1 p. S142
artikel
80 Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced esophagogastric cancer: a network meta-analysis Ter Veer, E.
2017
72 S1 p. S85-S86
artikel
81 Carcinoembryonic antigen, C-reactive protein and lactate dehydrogenase measurement in pleural fluid of patients with malignant pleural effusion. A case–control study with multivariate analysis Lumachi, F.
2017
72 S1 p. S179-S180
artikel
82 Cardiovascular risk factors in breast cancer survivors: Analysis of NHANES 2010–2013 Godfrey Bukenya, Y.
2017
72 S1 p. S38
artikel
83 Cervical cancer: state of cancer care and ways of its improvement in the Republic of North Ossetia-Alania in 1990–2014 Bosieva, A.
2017
72 S1 p. S97
artikel
84 Cervical cancer – treatment outcomes and failure Fatima, A.
2017
72 S1 p. S87-S88
artikel
85 Changes in cognitive impairment in ovarian cancer patients receiving chemotherapy; a pilot study Szabo, M.
2017
72 S1 p. S170
artikel
86 Changing trends in lung cancer characteristics and evolution of its diagnostic and surgical modalities Gupta, V.
2017
72 S1 p. S181
artikel
87 Chemotherapy does not impair parenchymal sparing surgery to treat colorectal liver metastases Evrard, S.
2017
72 S1 p. S52-S53
artikel
88 Chemotherapy of malignant glioma in rats by using multidrug-loaded biodegradable nanofibrous membranes Liu, S.J.
2017
72 S1 p. S46
artikel
89 Chronic radiation-associated dysphagia (RAD) after curative reirradiation or chemo-reirradiation in head and neck cancer Gutierrez Bayard, L.
2017
72 S1 p. S109
artikel
90 Circulating levels of cell free DNA in serum of head and neck cancer patients with special relation to clinicopathological status and stage of the disease – a pilot study from a developing country with a high incidence of tobacco related cancers Anand, A.
2017
72 S1 p. S113
artikel
91 Classifying variants in the CHEK2 gene: the importance of collaboration Espenschied, C.
2017
72 S1 p. S25
artikel
92 Clear cell renal carcinoma: report of four cases Polo Silveira, L.
2017
72 S1 p. S144-S145
artikel
93 Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx) Gullo, G.
2017
72 S1 p. S44
artikel
94 Clinical impact of MRI vs computed tomography in the diagnostic work-up of colon cancer patients Lahaye, M.
2017
72 S1 p. S54
artikel
95 Clinical management of localized leiomyosarcoma: a single center experience Greto, D.
2017
72 S1 p. S154-S155
artikel
96 Clinical outcome of diffuse large B cell lymphoma in Menoufia, Egypt in 5 years Sohaib, A.
2017
72 S1 p. S100
artikel
97 Clinical outcomes of endoscopic resection for head and neck cancer invading the subepithelial layer Abiko, S.
2017
72 S1 p. S110
artikel
98 Clinical presentation and outcome of a child with Fanconi anemia and acute promyelocytic leukemia (APL): case report Eissa, S.
2017
72 S1 p. S147-S148
artikel
99 Clinical prognostic markers in stage IIIB melanoma Madu, M.
2017
72 S1 p. S126-S127
artikel
100 Clinical safety and activity from a phase 1 study of LOXO-101, a selective TRKA/B/C inhibitor, in solid-tumor patients with NTRK gene fusions Hong, D.S.
2017
72 S1 p. S148
artikel
101 Clinical significance of caveolin-1 and fibronectin in pancreatic cancer Bilgin Doğru, E.
2017
72 S1 p. S78-S79
artikel
102 Clinical significance of D2-40 and CD31, lymphatic and blood vessel invasion markers, in gastric cancer Ihvan, A.
2017
72 S1 p. S77
artikel
103 Clinical significance of expression of Cripto-1 and evaluation of its role as biomaker in oropharyngeal squamous cell carcinoma Sumath Kumar, M.
2017
72 S1 p. S80
artikel
104 Clinician-guided versus USS-guided lymph node fine needle aspiration: Should we be performing more biopsies in clinic? Strong, A.
2017
72 S1 p. S116
artikel
105 Clinicoepidemiological study of breast cancer patients at Clinical Oncology Department Ain Shams University: five years retrospective study Gado, N.
2017
72 S1 p. S20
artikel
106 Clinicopathological characteristics and treatment of breast cancer among elderly patients at Tokyo Metropolitan Cancer Center Onishi, M.
2017
72 S1 p. S157
artikel
107 Clinic-pathologic study of gastric and esophageal malignancies at the National Cancer Institute, Cairo University, Egypt, 2008–2012 Aslan, M.
2017
72 S1 p. S80
artikel
108 Colorectal cancer and its awareness Fatima, A.
2017
72 S1 p. S50
artikel
109 Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4;14) and t(14;16) chromosome aberrations Katalinic, D.
2017
72 S1 p. S100-S101
artikel
110 Common attributes in mutation carriers identified in a 32-gene hereditary cancer panel Panos Smith, L.
2017
72 S1 p. S149
artikel
111 Communication between clinicians and patients with advanced cancer: assessing the ‘face validity’ and acceptability of a serious illness care guide to improve clinical communication McGlinchey, T.
2017
72 S1 p. S131
artikel
112 Comparative analysis of results of randomised trials on LDCT lung cancer screening Autier, P.
2017
72 S1 p. S177
artikel
113 Comparative effectiveness of initiating colorectal cancer (CRC) screening (scr) at age 45 Barzi, A.
2017
72 S1 p. S157
artikel
114 Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs) Shrestha, A.
2017
72 S1 p. S136
artikel
115 Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs) Eberhardt, W.E.E.
2017
72 S1 p. S136
artikel
116 Comparative study of Doppler, MAGS, and CD31 assay as vascularity index in advanced breast carcinoma Srivastava, V.
2017
72 S1 p. S23
artikel
117 Comparing best practice in pathways to breast cancer diagnosis for Indian women in the UK and India: a documentary analysis Khambhaita, P.
2017
72 S1 p. S157-S158
artikel
118 Comparing quality of glioblastoma resections between care teams Müller, D.
2017
72 S1 p. S46-S47
artikel
119 Comparison of expectations between medical oncologists (MO) and hepatobiliary surgeons (HS) regarding the indications for liver metastatectomy Yusuf, D.
2017
72 S1 p. S51
artikel
120 Comparison of MRI, PET-CT, and frozen biopsy in the evaluation of lymph node status before fertility-sparing radical trachelectomy in early stage cervical cancer Lee, G.
2017
72 S1 p. S92
artikel
121 Comparison of survival rates for diffuse large B-cell lymphoma with or without GI involvement in Songklanagarind Hospital Pulputtapong, J.
2017
72 S1 p. S173
artikel
122 Comparison of two-dimensional (2D)- and three-dimensional (3D)-culture models as drug testing platforms in GIST: experience with axitinib in vitro Martínez-Marín, V.
2017
72 S1 p. S155
artikel
123 Complete mesogastrium excision (CME) can reduce cancer leak from mesogastrium during D2 radical gastrectomy in patients with advanced gastric cancer Xie, D.
2017
72 S1 p. S84
artikel
124 Concurrent chemoradiation (CCRT) or radiotherapy with anti-EGFR directed monoclonal antibody (anti-EGFR) or CCRT + anti-EGFR in locoregionally advanced head-and-neck squamous cell carcinoma (LA-HNSCC): a comprehensive review of randomized data Specenier, P.
2017
72 S1 p. S105-S106
artikel
125 Contrasting male and female in lung cancer mortality trend in Albania Kraja, F.
2017
72 S1 p. S181
artikel
126 Contributions of patient-, tumor-, and treatment-related factors to the patients’ outcome after curative liver resection among Egyptian patients with metastatic colorectal tumor Kamal, M.
2017
72 S1 p. S63
artikel
127 Cooperative signaling of FHIT and p53 modulates celecoxib-induced growth inhibition through Akt and MDM2 signaling crosstalk in MCF-7 breast cancer cells Gharghabi, M.
2017
72 S1 p. S23
artikel
128 Correlation between BI-RADS classification and histopathological findings of breast lesions in Albanian women Hoti, A.
2017
72 S1 p. S13-S14
artikel
129 Correlation between symptoms, endoscopic features and treatment response in immunotherapy induced colitis Geukes Foppen, M.
2017
72 S1 p. S159
artikel
130 Correlation of circulating T-cells in pre-operative blood to intratumoral density and location of CD3+ and CD8+ T-cells in colorectal cancer: a potential for an immunoscore by liquid biopsy? Hagland, H.R.
2017
72 S1 p. S49-S50
artikel
131 Correlation of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) to lymph node (SLN) involvement in breast cancer Tolan, K.H.
2017
72 S1 p. S34
artikel
132 Correlation of pre-treatment 18F-FDG PET/CT metabolic parameters with short-term efficacy of radiotherapy for non-small cell lung cancer Ma, C.
2017
72 S1 p. S183
artikel
133 Cost benefit of prophylactic filgrastim in breast cancer patients treated with adjuvant docetaxel Sohaib, A.
2017
72 S1 p. S118
artikel
134 Cost-effectiveness of lipegfilgrastim from the Mexican payer perspective Szende, A.
2017
72 S1 p. S117
artikel
135 Curative partial pelvic exenterations for locally advanced rectal and sigmoid cancer with recto-vaginal and recto-vesical fistulas Kryvorotko, I.
2017
72 S1 p. S61
artikel
136 CXCR4 promotes adhesion capacity and activates the AKT signalling pathway in colorectal cancer cells Zheng, F.
2017
72 S1 p. S68
artikel
137 Defining the individual internal gross tumor volume of hepatocellular carcinoma using 4DCT and MRI-T2 images by deformable registration Ma, C.
2017
72 S1 p. S76
artikel
138 Demonstration of pharmacokinetic and pharmacodynamic equivalence in healthy volunteers for B12019, a proposed pegfilgrastim biosimilar Roth, K.
2017
72 S1 p. S37
artikel
139 Determination of level of job satisfaction and burnout of oncology nurses Koç, Z.
2017
72 S1 p. S133
artikel
140 Determination of TGF-β1 polymorphism at −509 C/T promoter region in HCV patients with and without HCC Ramiz, A.
2017
72 S1 p. S76
artikel
141 Development of biosensor for non-invasive oral cancer detection Yadav, B.K.
2017
72 S1 p. S138-S139
artikel
142 Diagnostic accuracy comparison between preoperative imaging study and sentinel lymph node biopsy during robotic or laparoscopic surgery in the detection of endometrial and cervical cancer regional lymph node metastasis Lee, G.
2017
72 S1 p. S97-S98
artikel
143 Diagnostic delay in primary osteosarcoma (OST) and Ewing sarcoma (ES) of bone in relation to metabolic activity on FDG PET/CT Van de Luijtgaarden, A.
2017
72 S1 p. S153
artikel
144 Diagnostic of the prostate cancer recurrence in patients after radical prostatectomy by multiparametric MRI vs PET/CT Kossov, F.
2017
72 S1 p. S189
artikel
145 Diagnostic performance of whole-body diffusion-weighted imaging compared to PET-CT plus brain MRI in staging clinically resectable lung cancer Usuda, K.
2017
72 S1 p. S178
artikel
146 Diagnostic usefulness of galectin 3 as surrogate biomarker for differentiating benign from malignant thyroid lesions Edris, A.
2017
72 S1 p. S103
artikel
147 DIALOG task force for definition of a geriatric minimum data set for clinical oncology research Paillaud, E.
2017
72 S1 p. S114
artikel
148 Differential survival from colorectal cancer and health expenditure in 3 European countries Sampaio Soares, A.
2017
72 S1 p. S122
artikel
149 Different quality of treatment in retroperitoneal sarcomas according to hospital-case volume and surgeon-case volume: a retrospective regional analysis in Italy Sandrucci, S.
2017
72 S1 p. S152
artikel
150 Difficulties in providing palliative care for metastatic breast cancer patients in rural India (West Bengal) – experience of an NGO Manna, A.
2017
72 S1 p. S161
artikel
151 Diffuse large B-cell lymphoma in the Northern Tunisian population: Incidence, trend and projection Ben Khadhra, H.
2017
72 S1 p. S142
artikel
152 Direct linear correlation between serum vascular endothelial growth factor (VEGF) and Ki-67 (MIB-1 rate) in women with pT1-2 breast cancer Lumachi, F.
2017
72 S1 p. S11
artikel
153 Distress among women taking part in surgical continuity of care for breast cancer: a mixed methods study Jørgensen, L.
2017
72 S1 p. S34-S35
artikel
154 Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma Sun, C.
2017
72 S1 p. S80
artikel
155 Disulfiram − an anti-alcoholism medicine will give cancer patients new hope Wang, W.
2017
72 S1 p. S48
artikel
156 Does cardiotoxicity management represent a rare bird for cancer nursing care delivery? An Italian study on nurses’ self-efficacy Ghizzardi, G.
2017
72 S1 p. S119-S120
artikel
157 Does combination of neoadjuvant chemotherapy and therapeutic mammoplasty reduces the need for mastectomy? El Gammal, M.
2017
72 S1 p. S22
artikel
158 Does IGF2BP1 (insulin like growth factor 2 binding protein 1) drive ETV6-RUNX1 positive B-acute lymphoblastic leukemia? Palanichamy, J.K.
2017
72 S1 p. S99
artikel
159 Does post-induction chemotherapy PET/CT response predict outcome in young adult nasopharyngeal carcinoma? Prospective study from CCHE Ahmed, S.A.
2017
72 S1 p. S145
artikel
160 Do microRNAs dictate response to drugs in colon cancer patients? Ramakrishna, M.
2017
72 S1 p. S70-S71
artikel
161 Dose response relationship of nuclear changes with fractionated concomitant chemoradiotherapy in assessing chemo-radiosensitivity of peritumoural area in oral squamous cell carcinoma patients Kashif, M.
2017
72 S1 p. S106
artikel
162 Dosimetric advantage of Deep Inspiration Breath Hold in left breast radiotherapy: comparative analysis with free breathing Rolo, A.S.
2017
72 S1 p. S26
artikel
163 Dosimetric comparison of 3-dimensional conformal radiotherapy, volumetric modulated ARC therapy, and helical tomotherapy for postoperative gastric cancer patients Onal, C.
2017
72 S1 p. S81
artikel
164 Down regulation of PDGFRα gene is associated with imatinib induced thrombocytopenia in chronic myeloid leukaemia Guru, S.A.
2017
72 S1 p. S98-S99
artikel
165 Downsizing of locally advanced stage III (bulky) BRAF V600E/K melanoma with combination targeted therapy to achieve R0 resection Haanen, J.
2017
72 S1 p. S124
artikel
166 Dutch national head and neck plan comparison significantly improved treatment plan quality Verbakel, W.
2017
72 S1 p. S102
artikel
167 E- and N-cadherin expression in prostate cancer as a sign of epithelial–mesenchymal transition Puchinskaya, M.
2017
72 S1 p. S191
artikel
168 Early detection of pancreatic cancer among diabetic patients: results from prescription database analyses Autier, P.
2017
72 S1 p. S71
artikel
169 Early mortality in children under 12 years with acute lymphoblastic leukemia with high white blood cell counts, in the period 2012-2013 in the National Children's Hospital Benjamin Bloom Duran Rodriguez, D.J.
2017
72 S1 p. S144
artikel
170 Early phase clinical trials conducted in North America are more likely to exclude breast cancer patients based on organ function and comorbidities compared to other countries: Analysis of 484 studies Mariotti, V.
2017
72 S1 p. S25
artikel
171 Editorial Board 2017
72 S1 p. ii
artikel
172 Effectiveness of a relaxation intervention technique (progressive muscle relaxation and guided imagery techniques) to reduce anxiety of parents of hospitalized children Tsitsi, T.
2017
72 S1 p. S143
artikel
173 Effect of delaying local control radiotherapy on outcome of localized pediatric bladder/prostate rhabdomyosarcoma Ahmed, S.A.
2017
72 S1 p. S146
artikel
174 Effect of prior systemic therapy on clinical outcomes with cabozantinib vs everolimus in advanced renal cell carcinoma: Results from the phase 3 METEOR study Grande, E.
2017
72 S1 p. S197-S198
artikel
175 Effect of radiotherapy for breast cancer on the prognosis of a subsequent myocardial infarction Boekel, N.B.
2017
72 S1 p. S29
artikel
176 Effects of a nursing intervention aimed at reducing symptom burden during chemotherapy (CHEMO-SUPPORT): a sequential before-after study Coolbrandt, A.
2017
72 S1 p. S166
artikel
177 Effects of a psychosocial intervention programme on improving outcomes of patients with a stoma He, H.
2017
72 S1 p. S162
artikel
178 Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2 Sonke, G.S.
2017
72 S1 p. S1-S2
artikel
179 Efficacy of cabozantinib vs everolimus in advanced renal cell carcinoma with bone metastases: results from the phase 3 METEOR study Bracarda, S.
2017
72 S1 p. S196
artikel
180 Efficacy of internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors with a DSM-IV diagnosis of sexual dysfunction: results of a randomized controlled trial Hummel, L.
2017
72 S1 p. S7-S8
artikel
181 Efficacy of pembrolizumab in patients with advanced mucosal melanoma enrolled in the KEYNOTE-001, 002, and 006 studies Butler, M.
2017
72 S1 p. S123
artikel
182 Efficacy of postoperative radiotherapy in patients with pathological stage N2 EGFR wild type adenocarcinoma & squamous cell carcinoma lung cancer Wu, S.-Y.
2017
72 S1 p. S182
artikel
183 Eight-year follow up results of the OTOASOR Trial: The Optimal Treatment Of the Axilla − Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial Sávolt, Á.
2017
72 S1 p. S1
artikel
184 Elevated levels of peripheral blood T lymphocytes are predictors of complete response to chemoradiotherapy in patients with locally advanced rectal cancer Deidda, S.
2017
72 S1 p. S60
artikel
185 Enhanced recovery after surgery care versus traditional perioperative care for elective open colorectal cancer surgery Abdelaziz, M.
2017
72 S1 p. S60-S61
artikel
186 Erythropoietin exhibit angiogenic potential and the role of erythropoietin receptor in lung cancer cells Liu, X.
2017
72 S1 p. S179
artikel
187 Ethnic disparities in breast cancer survival in New Zealand: Why do Māori fare poorly? Seneviratne, S.
2017
72 S1 p. S15-S16
artikel
188 EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL) Ascierto, P.
2017
72 S1 p. S128
artikel
189 Evaluating cervical lymph node metastasis: a comparative study of CT scan and physical examination with cytological results Arora, N.
2017
72 S1 p. S103-S104
artikel
190 Evaluating the potential of dabigatran etexilate in treatment of metastatic colon cancer Sangole, P.
2017
72 S1 p. S70
artikel
191 Evaluating the scientific basis of quality indicators in colorectal cancer care: results of a systematic review Keikes, L.
2017
72 S1 p. S53-S54
artikel
192 Evaluation of a knowledge-based planning solution for cervical cancer Ma, C.
2017
72 S1 p. S93-S94
artikel
193 Evaluation of early implementation of tumor-infiltrating lymphocytes in treating advanced melanoma in an academic setting: a constructive technology analysis Lindenberg, M.
2017
72 S1 p. S130-S131
artikel
194 Evaluation of guideline adherence in colorectal cancer treatment in The Netherlands: a survey among medical oncologists by the Dutch Colorectal Cancer Group (DCCG) Keikes, L.
2017
72 S1 p. S68-S69
artikel
195 Evaluation of HE4 marker in prediction and diagnosis of disease recurrence in female patients with recurrent ovarian cancer Strojna, A.
2017
72 S1 p. S174
artikel
196 Evaluation of Her-2/neu receptor status and its association with age, menopausal status, histopathological features and ER/PR status in operable carcinoma of the breast Verma, N.
2017
72 S1 p. S21
artikel
197 Evaluation of hyperthermic intraperitoneal chemotherapy (HIPEC) and its peri-operative management for peritoneal surface malignancies – single institute Indian experience Naidu, N.
2017
72 S1 p. S83
artikel
198 Evaluation of prognostic and predictive value of novel markers (NF-κB and ODC) alone and in combination with other markers for patients with breast cancer Shapochka, D.
2017
72 S1 p. S12
artikel
199 Evaluation of serum of breast cancer patients using high resolution magic angle proton magnetic resonance spectroscopy (HR-MAS): a search for possible biomarker? Kumar, S.
2017
72 S1 p. S13
artikel
200 Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in large cell neuroendocrine carcinoma Prelaj, A.
2017
72 S1 p. S180-S181
artikel
201 Evaluation of weight status during the time between ileostomy formation and closure in individuals who were operated due to rectal cancer Doğan, H.
2017
72 S1 p. S62-S63
artikel
202 Evolution of resources 2 and 5 years after cancer diagnosis: evidence from the French VICAN surveys Alleaume, C.
2017
72 S1 p. S171
artikel
203 Examination of the prognostic factors of CART (Cell-free and Concentrated Ascites Reinfusion Therapy) in cancer patients with malignant ascites Otake, Y.
2017
72 S1 p. S164
artikel
204 Examining the direct and indirect effects of socioeconomic status (SES) on colorectal cancer risk using structural equation modeling Zhao, J.
2017
72 S1 p. S56
artikel
205 Exploring the potential for PD-1 blockade in sarcoma patients Van Erp, A.
2017
72 S1 p. S152-S153
artikel
206 Expression of ErbB-2 (Her-2/neu) and survivin gene (BIRC5) in tumor infiltrating lymphocytes (TILs) in breast cancer Shlyakhtunou, Y.
2017
72 S1 p. S16-S17
artikel
207 Factors affecting anxiety and depression among breast cancer patients: a study from Northern India Srivastava, V.
2017
72 S1 p. S163
artikel
208 Factors affecting survival in Egyptian patients with triple negative breast cancer Kamal, M.
2017
72 S1 p. S10
artikel
209 Factors influencing communication skills and abilities for empathy of oncology nurses Koç, Z.
2017
72 S1 p. S130
artikel
210 Factors influencing the 3-year recurrence of liver carcinoma after surgery Molek, R.
2017
72 S1 p. S84
artikel
211 Familial interaction patterns during the palliative phase of a family member living with cancer Möllerberg, M.L.
2017
72 S1 p. S162
artikel
212 FAT1 knockdown led to reduce EMT and stemness genes expression in hypoxic glioma Srivastava, C.
2017
72 S1 p. S46
artikel
213 FBXO39, ETS-1 and H3F3B genes as three candidates for prognosis of colorectal cancer metastasis Motalebzadeh, J.
2017
72 S1 p. S137
artikel
214 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma Bhoriwal, S.K.
2017
72 S1 p. S22
artikel
215 Feasibility and acceptability of follow-up care for prostate cancer in primary care Heins, M.
2017
72 S1 p. S186
artikel
216 Feasibility and safety of a therapeutic strategy using selective transarterial radioembolization followed by surgery for hepatocellular carcinoma in cirrhotic patients Lemaire, M.
2017
72 S1 p. S84-S85
artikel
217 Feasibility of advanced practice nurse in lung cancer consultations during early treatment: a phase II study Serena, A.
2017
72 S1 p. S160
artikel
218 Feasibility of extended sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer patients Maeshima, Y.
2017
72 S1 p. S33
artikel
219 Feasibility of knowledge-based IMRT planning automatic optimization for cervical cancer Ma, C.
2017
72 S1 p. S93
artikel
220 Feasibility of Port-a-cath insertion through external jugular vein cut down in cancer patients Sakkary, M.
2017
72 S1 p. S31
artikel
221 Febrile neutropenia in adjuvant and neoadjuvant chemotherapy for breast cancer: a retrospective study in routine clinical practice from a single institution Bacrie, J.
2017
72 S1 p. S170
artikel
222 Financial burden of cancer drug treatment in Lebanon Elias, F.
2017
72 S1 p. S117
artikel
223 First findings: Cooperation of two different cell membrane proteins in breast cancer Turgut Cosan, D.
2017
72 S1 p. S18
artikel
224 First-line afatinib for advanced EGFR mutation-positive (EGFRm+) NSCLC: analysis of long-term responders in the Phase III LUX-Lung 3, 6 and 7 trials Schuler, M.
2017
72 S1 p. S176-S177
artikel
225 Follow-up examinations performed by radiation oncologists after radiotherapy in Japan Tanaka, O.
2017
72 S1 p. S129-S130
artikel
226 Fotemustine as a third line treatment of high-grade glioma Ramirez Daffos, P.
2017
72 S1 p. S48-S49
artikel
227 Frequency and sites of stage I renal cell carcinoma progression Puchinskaya, M.
2017
72 S1 p. S194-S195
artikel
228 Frozen section analysis versus imprint cytology for assessment of safety margins in breast conservation surgery Moustafa, A.
2017
72 S1 p. S30
artikel
229 Genomic characterization of liver metastases from colorectal cancer patients Sayagués, J.M.
2017
72 S1 p. S52
artikel
230 Global named patient use (NPU) program of afatinib in heavily pretreated advanced NSCLC patients who progressed following prior therapies, including erlotinib or gefitinib Hochmair, M.
2017
72 S1 p. S183-S184
artikel
231 Gremlin 1 expression correlates with prognostic features and survival in breast carcinoma Zabkiewicz, C.
2017
72 S1 p. S17-S18
artikel
232 Head and neck cancer in a developing country – a hospital based retrospective study across 10 years from Pakistan Faisal, M.
2017
72 S1 p. S104
artikel
233 “Health: A Blessing to Defend, a Right to Uphold” – a manifesto for the rights of oncology patients Mancuso, A.
2017
72 S1 p. S121
artikel
234 Health-related quality of life analysis from the accelerated partial breast irradiation IMRT-Florence phase 3 trial: Impact of age and scores trend over time Meattini, I.
2017
72 S1 p. S8
artikel
235 Health-related quality of life in adolescent and young adult (AYA) cancer patients: a longitudinal study Husson, O.
2017
72 S1 p. S139
artikel
236 Hearing loss after cisplatin-based chemotherapy (CBCT) in testicular cancer survivors (TCSs): less than previously described Fosså, S.D.
2017
72 S1 p. S172-S173
artikel
237 HERITAGE: a phase III safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus herceptin Rugo, H.
2017
72 S1 p. S41
artikel
238 High experienced continuity in breast cancer care is associated with high health related quality of life and compatible with good medical quality and approved lead times Plate, S.
2017
72 S1 p. S24-S25
artikel
239 High-throughput mutational analysis of urothelial bladder carcinoma Nedjadi, T.
2017
72 S1 p. S192
artikel
240 Histopathological growth patterns: A novel prognostic biomarker in patients with resected colorectal liver metastases Galjart, B.
2017
72 S1 p. S66-S67
artikel
241 Holistic needs assessment and care plans for women with gynaecological cancer – do they improve cancer specific health related quality of life? A mixed-methods study Sandsund, C.
2017
72 S1 p. S175
artikel
242 How do cancer centres communicate clinical trials opportunities to patients on their websites? Miqueu, P.
2017
72 S1 p. S132
artikel
243 Hypofractionated radiotherapy after conservative surgery in breast cancer patients: a phase I-II trial (MARA-1) Pieri, M.
2017
72 S1 p. S28-S29
artikel
244 Hypothyroidism following adjuvant radiation in oral cavity carcinoma: a study of 60 cases at tertiary care institute Rao, D.
2017
72 S1 p. S107
artikel
245 Hypo- vs normofractionated radiation therapy of early stage breast cancer in the randomized DBCG HYPO trial Offersen, B.V.
2017
72 S1 p. S9-S10
artikel
246 Identification and critical analysis of metastatic breast cancer policies to advance access to care and treatment in Europe: Research methodology and approaches used to survey the current policy environment Thrift-Perry, M.
2017
72 S1 p. S120-S121
artikel
247 Identifying best performing hospitals in colorectal cancer care; is it possible? Van Groningen, J.
2017
72 S1 p. S67
artikel
248 Immunohistochemical expression of MAGE-A1, MAGE-A3/4 and NY-ESO-1 antigens in patients with non-small cell lung cancer: Is there any impact on the specific immunotherapy? Katalinic, D.
2017
72 S1 p. S186
artikel
249 Immunological and first anti-tumor data of the TLR9 agonist dSLIM2006 Volz, B.
2017
72 S1 p. S149-S150
artikel
250 Impact of baseline serum lactate dehydrogenase concentration on the efficacy of pembrolizumab and ipilimumab in patients with advanced melanoma: data from KEYNOTE-006 Long, G.V.
2017
72 S1 p. S122-S123
artikel
251 Impact of chronic neuropathic pain on job retention among cancer survivors: evidence from the French national survey VICAN Bendiane, M.
2017
72 S1 p. S6
artikel
252 Impact of neoadjuvant chemotherapy on breast cancer survival: a systematic review and meta-analysis Pathak, M.
2017
72 S1 p. S42-S43
artikel
253 Impact of prolonged postoperative ileus on surgical outcome in elective colorectal cancer resections Nestorovic, M.
2017
72 S1 p. S63
artikel
254 Impact of toxicities and neurocognitive impairment on the health related quality of life (HR-QoL) for survivors of medulloblastoma Stone, J.
2017
72 S1 p. S171
artikel
255 Implementation of the 7th edition AJCC staging system: effects on staging and survival for pT1 melanoma. A Dutch population based study Oude Ophuis, C.
2017
72 S1 p. S127
artikel
256 Improved survival of HPV-positive non-oropharyngeal head and neck squamous cell carcinoma Ko, H.C.
2017
72 S1 p. S107
artikel
257 Improving radiotherapy of squamous cell carcinoma of the head and neck (HNSCC) through a continuous process of biological based clinical trials − a 40-year experience from the Danish Head and Neck Cancer Group − DAHANCA Overgaard, J.
2017
72 S1 p. S102
artikel
258 IMRT and simultaneous hypofractionated boost combined with chemotherapy for squamous cell anal cancer: All in 25 fractions Diaz Gomez, L.
2017
72 S1 p. S58
artikel
259 IMRT vs. VMAT for breast cancer treatment using a Monte Carlo algorithm Sanchez Mazon, J.
2017
72 S1 p. S27
artikel
260 Incidence and histologic patterns of thyroid cancer in Sri Lanka 2001–2010 Seneviratne, S.
2017
72 S1 p. S104
artikel
261 Incidence and prognostic significance of extramural venous invasion in T3–4 esophageal cancer Faiz, Z.
2017
72 S1 p. S78
artikel
262 Incidence of colorectal cancer in Sri Lanka: analysis of the cancer registry data and comparison with other South Asian populations Wickramasinghe, D.
2017
72 S1 p. S52
artikel
263 Incidence of gastric cancer in Sri Lanka: analysis of the cancer registry data and comparison with other South Asian populations Wickramasinghe, D.
2017
72 S1 p. S73-S74
artikel
264 Incidents reported at the Cytotoxic Preparation Unit of the National Institute of Oncology, Rabat, Morocco Ouggague, K.
2017
72 S1 p. S133
artikel
265 Individual diagnosis of chemotherapy-associated liver function impairment before surgery of hepatic colorectal metastases Lock, J.F.
2017
72 S1 p. S65
artikel
266 Induction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors Bimonte, S.
2017
72 S1 p. S188-S189
artikel
267 Inhibitory effect of (−)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MIA Paca-2 cell growth Bimonte, S.
2017
72 S1 p. S73
artikel
268 Initial experience of a single cancer care centre in treating left breast cancer using first Helical Tomotherapy-H in India Hanumanthappa, N.
2017
72 S1 p. S26-S27
artikel
269 Innovation in cancer care delivery Moser, L.
2017
72 S1 p. S130
artikel
270 Inspection of cervix using acetic acid – a good alternative to Pap smear in underdeveloped countries Fatima, A.
2017
72 S1 p. S88
artikel
271 Integrated efficacy and safety analysis of the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with high-grade ovarian carcinoma (HGOC) Oaknin, A.
2017
72 S1 p. S95
artikel
272 Integrative analysis of bone marrow disease in neuroblastoma patients by DNA, RNA and protein markers Druy, A.
2017
72 S1 p. S143
artikel
273 Interplay of MDM2 and PSMA modulates the secretion of the MMPs through AKT phosphorylation in breast cancer cells Bradbury, R.
2017
72 S1 p. S39
artikel
274 Intra operative sentinel lymph node positivity by methylene blue dye and its association with other dissected lymph node by histopathological examination in colorectal cancer Mohan, B.
2017
72 S1 p. S57
artikel
275 Intraoral stent reduces set-up errors in image guided radiotherapy for head and neck cancer patients Tarutani, K.
2017
72 S1 p. S108
artikel
276 Investigating the effect of a supportive complementary and alternative medicine (CAM) nursing intervention to improve quality of life outcomes in gynecologic oncology patients – first report of a randomized controlled trial Klafke, N.
2017
72 S1 p. S4-S5
artikel
277 Investigation of the role of VEGF-A +936C>T and −634G>C as prognostic and risk factors in breast cancer patients Vasileva, M.
2017
72 S1 p. S15
artikel
278 Involvement of SNPS in CDKN2A/B locus in childhood acute lymphoblastic leukemia susceptibility in the Spanish population Gutierrez-Camino, A.
2017
72 S1 p. S144
artikel
279 Involvement of SNPS in mir3117 and mir3689 in pediatric acute lymphoblastic leukemia susceptibility Guterrez-Camino, A.
2017
72 S1 p. S144
artikel
280 Ipsilateral breast recurrence after breast-conserving surgery in young Japanese patients with breast cancer Saita, C.
2017
72 S1 p. S33
artikel
281 Is hepatic volumetry sufficient for avoiding postoperative liver failure? A correlative study between future liver remnant volume and mebrofenin scintigraphy function after major hepatic resections Gonot-Gaschard, M.
2017
72 S1 p. S66
artikel
282 Is Indian breast cancer biology different from its western counterpart? A study of clinical & pathological correlation of biomolecular sub-typing of breast cancer in Northern India Paryani, J.
2017
72 S1 p. S12
artikel
283 Is it feasible to perform sentinel lymph node biopsy with only blue dye in early oral cancer? A large cancer center experience Vishnoi, J.R.
2017
72 S1 p. S111
artikel
284 ISO-005; An open-label, multiple-site, dose cohort, phase I/II study in patients with stage IV colorectal cancer Taflin, H.
2017
72 S1 p. S71
artikel
285 Isolated limb perfusion for melanoma is safe and effective in elderly patients Madu, M.
2017
72 S1 p. S126
artikel
286 Is there a role for antithrombotic prophylaxis in oncologic patients who undergo central venous access placement? Cefalì, M.
2017
72 S1 p. S140
artikel
287 Knowledge, attitude and practice and associated factors towards palliative care among nurses working in selected hospitals, Addis Ababa, Ethiopia Zewdu, F.
2017
72 S1 p. S161
artikel
288 KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer Nagy, A.
2017
72 S1 p. S180
artikel
289 Laparoscopic and open surgery for gastric cancer from a business intelligence viewpoint Tegels, J.
2017
72 S1 p. S119
artikel
290 LATE-BREAKING ABSTRACT: Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013-2014 Kim, H.
2017
72 S1 p. S129
artikel
291 Lipegfilgrastim highly cost-effective in reducing chemotherapy-induced neutropenia in breast cancer patients Akpo, E.I.H.
2017
72 S1 p. S44
artikel
292 Local adipodermal flap in decreasing fluid drainage and seroma formation after axillary lymph node dissection in breast cancer patients Sakkary, M.
2017
72 S1 p. S33
artikel
293 Local hyperthermia for inflammatory breast cancer Ragulin, Y.
2017
72 S1 p. S11-S12
artikel
294 Locally advanced cancer cervix: a systematic review and metaanalysis of 17 randomized trials to explore the therapeutic evidence for concurrent chemoradiotherapy over radiotherapy alone Datta, N.R.
2017
72 S1 p. S89
artikel
295 Locally advanced nasopharyngeal cancer – a 7-year retrospective analysis Nogueira, A.
2017
72 S1 p. S103
artikel
296 Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes Wu, S.-Y.
2017
72 S1 p. S109
artikel
297 Long-term follow-up features on rectal MRI during a ‘watch-and-wait’ approach in clinical complete responders after chemoradiotherapy: an update of 140 patients Lambregts, D.
2017
72 S1 p. S54
artikel
298 Long-term results of total mesorectal excision for rectal cancer: prospective single-center study Sidorov, D.
2017
72 S1 p. S63
artikel
299 Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach Thornton Snider, J.
2017
72 S1 p. S135-S136
artikel
300 Low cause-specific mortality in women treated for ductal carcinoma in situ of the breast Elshof, L.
2017
72 S1 p. S15
artikel
301 Low dose palliative radiotherapy for refractory aggressive lymphoma Tanaka, O.
2017
72 S1 p. S98
artikel
302 Lymphocyte count in surgically treated urological cancer patients is a sensitive marker of the status of the disease Yakovlev, P.
2017
72 S1 p. S195-S196
artikel
303 Magnetic resonance imaging in the evaluation of tumor node in breast cancer after neoadjuvant treatment Komiakhov, A.
2017
72 S1 p. S27
artikel
304 Magnolol exerts chemoprotective effect by attenuating the xenobiotic, anti-oxidative enzymes and inflammatory mediator in Wistar rats Verma, A.
2017
72 S1 p. S75-S76
artikel
305 Malignant pleural mesothelioma (MPM) evaluation with 11C-methionine PET/CT before and after talc pleurodesis Lopci, E.
2017
72 S1 p. S179
artikel
306 Malignant tumors in children: dynamics of disease and survival rate in Republic Northern Ossetia-Alania in 1990-2014 Bosieva, A.
2017
72 S1 p. S148
artikel
307 Management and early complications of totally implantable venous access port systems in 81 children diagnosed with cancer Astigarraga, I.
2017
72 S1 p. S146
artikel
308 Management and survival prognostic factors of metachronous second primary head and neck squamous cell carcinoma Wu, S.-Y.
2017
72 S1 p. S109
artikel
309 Management of symptomatic paediatric vertebral haemangiomas by an innovative technique Singh, P.
2017
72 S1 p. S47
artikel
310 Managing ethical considerations while researching vulnerable patient groups: glioma patient experiences of taking part in research interviews Farrell, S.
2017
72 S1 p. S163
artikel
311 MDR-1 C3435T transition and breast cancer risk: A meta-analysis in Asian population and a bioinformatics approach Zarrati, S.
2017
72 S1 p. S11
artikel
312 Medicinal ShenLingLan influences ovarian cancer cell migratory behaviour potentially through the GSK-3 pathway Owen, S.
2017
72 S1 p. S90
artikel
313 Melanoma, riding the rollercoaster: a longitudinal Grounded Theory study of the experiences of melanoma patients and their carers Bird, J.
2017
72 S1 p. S169-S170
artikel
314 Mena INV: A prospective bio-marker of cancer cells under hypoxia Bhagat, M.
2017
72 S1 p. S45-S46
artikel
315 Mesh versus acellular dermal matrix in immediate implant based breast reconstruction – a prospective randomized trial Gschwantler-Kaulich, E.
2017
72 S1 p. S30
artikel
316 Metastatic melanoma: prognostic factors and survival in patients with brain metastases Frinton, E.
2017
72 S1 p. S124
artikel
317 Metformin reduces esophageal cancer risk in Taiwanese patients with type 2 diabetes Tseng, C.H.
2017
72 S1 p. S77-S78
artikel
318 MicroRNA-330 replacement effect on growth and metastasis inhibition in melanoma A375 cancer cell line Sehati, N.
2017
72 S1 p. S125
artikel
319 Microsurgical reconstruction in patients with oropharyngeal cancer Polyakov, A.
2017
72 S1 p. S111
artikel
320 Modulation of platelet levels by an anti-IL-1α antibody (MABp1) in advanced colorectal cancer patients Hickish, T.
2017
72 S1 p. S70
artikel
321 Morbidity and mortality of D2 lymphadenectomy plus completed mesogastrium excision (D2+CME) versus traditional D2 lymphadenectomy in laparoscopic distal gastrectomy – an interim report of a single-centre, prospective, randomized trial (NCT01978444) Xie, D.
2017
72 S1 p. S72-S73
artikel
322 MRI-based periprostatic-fascia thickness measurements as tool to virtually predict postoperative erectile function after robot-assisted radical prostatectomy Van der Roest, R.
2017
72 S1 p. S195
artikel
323 MRI guided biopsy in patients with previously negative TRUS biopsy or suspicion of non-low grade disease on multiparametric MRI: High yield with predominantly intermediate to high risk prostate cancer found Heijmink, S.
2017
72 S1 p. S195
artikel
324 Multimodality treatment in operable sinonasal cancer: single center experience Desideri, I.
2017
72 S1 p. S107-S108
artikel
325 Multiple primary cancers: an exploratory research Van Thiel, L.
2017
72 S1 p. S135
artikel
326 Mutational status of Yin Yang 1 gene in rare sporadic insulinomas: the Indian scenario with a review Irshad, K.
2017
72 S1 p. S150-S151
artikel
327 Nab paclitaxel (Nab-P) and gemcitabine (G) first line chemotherapy (CT) in metastatic pancreatic cancer (mPC) patients (pts) relapsed after adjuvant treatment (ADJ T): A “real life” study Giordano, G.
2017
72 S1 p. S87
artikel
328 Naringin: a novel anticancer candidate against chemically induced hepatocellular carcinoma in rats Kumar, V.
2017
72 S1 p. S77
artikel
329 National breast cancer screening program in France: Results for 2013-2014 Rogel, A.
2017
72 S1 p. S158-S159
artikel
330 Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer Van der Geest, L.G.M.
2017
72 S1 p. S72
artikel
331 Nationwide survey on patients’ and professionals’ expectations on prognosis of metastatic colorectal cancer (mCRC) Sailas, L.
2017
72 S1 p. S50
artikel
332 Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer Van der Geest, L.G.M.
2017
72 S1 p. S86
artikel
333 Near infrared fluorescence imaging after intraoperative injection of indocyanine green to improve the staging during cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: results of a pilot prospective study (NCT02032485) Liberale, G.
2017
72 S1 p. S53
artikel
334 Near total laryngectomy – complications, function & survival: a sixteen-year institutional experience Gupta, N.
2017
72 S1 p. S110
artikel
335 Neoadjuvant metronomic chemotherapy in locally advanced head and neck cancers – feasibility study Sultania, M.
2017
72 S1 p. S106
artikel
336 NETs: Less common – still misunderstood Jervis, N.
2017
72 S1 p. S151
artikel
337 New biomarker of tumor progression of breast cancer – surviving gene expression in the primary tumor and circulating tumor cells Shlyakhtunou, Y.
2017
72 S1 p. S16
artikel
338 Next-generation sequencing for miRNA profiling of stool and plasma samples of patients with colorectal cancer or precancerous lesions Gallo, G.
2017
72 S1 p. S62
artikel
339 NOTCH2 and PTP4A3 gene copy number alterations are associated with prognosis and support novel therapeutic strategies for malignant pleural mesothelioma Leon, L.G.
2017
72 S1 p. S181-S182
artikel
340 Nottingham Prognostic index (NPI) − a simple predictive tool for operable breast cancer − utility in non screened cohort Agrawal, S.
2017
72 S1 p. S14
artikel
341 Novel monastrol derivatives exert potent anti-breast cancer activity via inhibition of ubiquitin conjugating enzyme Rad6B Singh, U.P.
2017
72 S1 p. S36-S37
artikel
342 Novel therapies in chronic lymphocytic leukaemia (CLL): quantifying the impact on patient relevant outcome measures Singh, M.
2017
72 S1 p. S99-S100
artikel
343 NSC-745887, a novel small molecule, modulates DcR 3 and ATM signalings in brain cancer Fann, L.Y.
2017
72 S1 p. S47-S48
artikel
344 Oncological emergencies in colorectal carcinoma Thangasamy, B.M.
2017
72 S1 p. S85
artikel
345 Oncological outcomes of colon carcinoma: 10 year experience from a low income country Nasir, I.U.I.
2017
72 S1 p. S62
artikel
346 Oncology admissions to ITU: What factors should influence the decision? Ng, K.
2017
72 S1 p. S172
artikel
347 Oncoplastic breast surgery is oncologically safe in locally advanced breast cancer after neoadjuvant chemotherapy, an Egyptian experience Youssef, M.
2017
72 S1 p. S30-S31
artikel
348 Oncoplasty in breast conservation surgery: cosmesis and oncological safety − a prospective study Mohammed Ilyas, M.I.
2017
72 S1 p. S32-S33
artikel
349 ONCOPRE: a new chemotherapy benefit prediction algorithm to assist with treatment decision making Yusuf, D.
2017
72 S1 p. S67-S68
artikel
350 One size fits no-one: A response to national strategy for cancer care Jervis, N.
2017
72 S1 p. S122
artikel
351 Online support community AYA4 (All information You have Asked for) for adolescents and young adults (AYAs) with cancer: evaluation and content analysis Kaal, S.
2017
72 S1 p. S159
artikel
352 Operations research for resource planning and -use in radiotherapy: a literature review Vieira, B.
2017
72 S1 p. S129
artikel
353 Optimal contouring and planning algorithm for surface dose in the treatment of chest wall radiation Aytac Arslan, S.
2017
72 S1 p. S29-S30
artikel
354 Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05) Van de Velde, C.J.H.
2017
72 S1 p. S9
artikel
355 Optimal use of pegfilgrastim (a long-acting granulocyte-colony stimulating factor [G-CSF]) to manage chemotherapy-induced febrile neutropenia (FN) in haematological malignancies: consensus guidance recommendations Aapro, M.
2017
72 S1 p. S167
artikel
356 Optimizing management of glioma patients in resource poor centres: study of 80 high grade gliomas Singh, S.
2017
72 S1 p. S45
artikel
357 Outcome of children with medulloblastoma at a tertiary care hospital in Karachi, Pakistan Hamid, S.A.
2017
72 S1 p. S145-S146
artikel
358 Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis De Lisi, D.
2017
72 S1 p. S190
artikel
359 Outcomes of breast cancer patients older than 80 years treated with adjuvant radiotherapy Barrientos, R.
2017
72 S1 p. S27-S28
artikel
360 Outcomes of preoperative chemoradiotherapy for rectal cancer with lateral pelvic lymph node metastasis Takawa, M.
2017
72 S1 p. S52
artikel
361 Overall survival results from the phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinoma (METEOR) Schmidinger, M.
2017
72 S1 p. S187-S188
artikel
362 Palliative care in Egypt: the experience of the Gharbiah Cancer Society Hablas, M.
2017
72 S1 p. S161
artikel
363 Palliative surgery for advanced gastric cancer: A pilot study of 10 years experience in a tertiary referral center before and after centralization of surgical care De Wijkerslooth, E.
2017
72 S1 p. S83
artikel
364 Pancreatic glucagonoma associated with necrolytic migratory erythema: case report and clinical review Cardoso, D.
2017
72 S1 p. S151
artikel
365 Pancreatogenic complications of targeted therapy Dzhansyz, I.
2017
72 S1 p. S82
artikel
366 Parallel assessment of hypoxia in tumor and LN metastases increases prognostic value of hypoxia-specific PET imaging in locally advanced head-and-neck cancer – secondary analysis of the DDFMISO trial Bandurska-Luque, A.
2017
72 S1 p. S102-S103
artikel
367 Pathological diagnosis in pancreatic cancer pre-operatively – a reality or myth? Mohan, B.
2017
72 S1 p. S79
artikel
368 Pathological fracture and prognosis of high-grade osteosarcoma of the extremities. An analysis of 2,847 consecutive cooperative osteosarcoma study group (COSS) patients Kelley, L.
2017
72 S1 p. S152
artikel
369 Patient counselling at dispensing of oral anticancer drugs in Europe Eberl, A.
2017
72 S1 p. S132
artikel
370 Patient development of an electronic tool to empower adolescents and young adults with cancer Pappot, H.
2017
72 S1 p. S175-S176
artikel
371 Patient involvement in research agenda – an evaluation of the methods applied Piil, K.
2017
72 S1 p. S167
artikel
372 Patient mobility for radical prostatectomy in the English NHS: its impact on service configuration and technology integration Aggarwal, A.
2017
72 S1 p. S187
artikel
373 Patient nutritional status: serum albumin levels a predictive indicator of survival in patients with metastatic breast cancer Courtney, D.
2017
72 S1 p. S35
artikel
374 Patient reported outcomes following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials. Presented on behalf of the START Trial Management Group Griffin, C.
2017
72 S1 p. S5-S6
artikel
375 Patient reported skin toxicity and experiences with barrier film on the breast during radiotherapy Møller, P.K.
2017
72 S1 p. S169
artikel
376 Patients’ guardians, Practitioners and Population (3Ps) opinions in pediatric oncology clinical trials in developing country: a cross-sectional survey Rashed, W.M.
2017
72 S1 p. S120
artikel
377 Patients’ perspectives on symmetrising breast reduction after oncoplastic surgery Smeele, H.
2017
72 S1 p. S36
artikel
378 Patterns of response to endocrine therapy in metastatic breast cancer Sundquist, M.
2017
72 S1 p. S42
artikel
379 Pembrolizumab for metastatic triple-negative breast cancer (mTNBC): long-lasting responses in the phase Ib KEYNOTE-012 study Nanda, R.
2017
72 S1 p. S38
artikel
380 Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study Necchi, A.
2017
72 S1 p. S2
artikel
381 Perceived social support, psychological resilience and gender differences among cancer survivors Srivastava, J.
2017
72 S1 p. S162
artikel
382 Perception of cervical cancer and human papillomavirus in Korean female university students Kim, H.
2017
72 S1 p. S90
artikel
383 Peri-operative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing? Booth, C.
2017
72 S1 p. S191
artikel
384 PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study Madu, M.
2017
72 S1 p. S127
artikel
385 Pharmacokinetic (PK) profile of quisinostat in combination with gemcitabine and cisplatin in patients (pts) with non-small cell lung cancer (NSCLC) or paclitaxel and carboplatin in pts with NSCLC or epithelial ovarian cancer Fedyanin, M.
2017
72 S1 p. S96
artikel
386 Phase 1b/2 study to evaluate eribulin mesylate in combination with pembrolizumab in patients with metastatic triple-negative breast cancer Tolaney, S.
2017
72 S1 p. S16
artikel
387 Phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H vs EU-Neulasta® in the prophylactic treatment of chemotherapy-induced neutropenia Waller, C.
2017
72 S1 p. S42
artikel
388 Phase II California Cancer Consortium trial of gemcitabine–eribulin combination (GE) in cisplatin ineligible patients (pts) with metastatic urothelial carcinoma (mUC): tolerability and toxicity report (NCI-9653; 1UM1CA186717-01, NO1-CM-2011-00038) Sadeghi, S.
2017
72 S1 p. S197
artikel
389 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors Forster, M.
2017
72 S1 p. S134
artikel
390 Phase 2 study of lenvatinib in patients with RET fusion-positive adenocarcinoma of the lung Velcheti, V.
2017
72 S1 p. S178
artikel
391 Phospho-Akt: a potential resistance marker to chemotherapy and therapy-target to restore sensitivity in pancreatic cancer Giovannetti, E.
2017
72 S1 p. S86
artikel
392 Piloting a transmural care pathway for glioma patients and their family caregivers: an explorative study of their perceptions Decadt, I.
2017
72 S1 p. S132
artikel
393 Population-based organized cervical cancer screening pilot program in France Hamers, F.
2017
72 S1 p. S158
artikel
394 Portal lymphodissection in surgery of liver metastatic lesions Ishchenko, R.
2017
72 S1 p. S82
artikel
395 Portal vein ligation vs ALPPS for colorectal metastatic liver cancer Sidorov, D.
2017
72 S1 p. S64
artikel
396 Positive sentinel node in the groin area: Extent of completion lymphadenectomy and prognosis for melanoma patients Oude Ophuis, C.
2017
72 S1 p. S127
artikel
397 Postoperative radiotherapy versus surgery alone for T1N1 and T2N0 oropharygeal squamous cell carcinoma: a nationwide and retrospective study Kadletz, L.
2017
72 S1 p. S104
artikel
398 Post-operative Recovery Exercise Programme using Yoga (PREPY). A feasibility study of the impact of yoga on the recovery of patients who have undergone surgical resection for lung cancer Clarke, K.
2017
72 S1 p. S173
artikel
399 Post-transplant cancers negatively affect survival of kidney transplant recipients: Results from the Italian multicentric cohort study Serraino, D.
2017
72 S1 p. S176
artikel
400 Potential diagnostic and prognostic value of lymphocytic mitochondrial DNA deletion in relation to folic acid status in hepatocellular carcinoma Omran, D.
2017
72 S1 p. S76-S77
artikel
401 Potential implication of IL-17B and IL-17RB in the progression of gastric cancer Sanders, A.
2017
72 S1 p. S87
artikel
402 Potential implication of SOCS-4 in pancreatic cancer development Feng, Y.
2017
72 S1 p. S75
artikel
403 Potential price reductions for cancer medicines on the WHO Essential Medicines List Barber, M.
2017
72 S1 p. S119
artikel
404 Prediction and prevention of liver failure after major liver resections for liver metastases of colorectal cancer: the role of functional tests Sidorov, D.
2017
72 S1 p. S64
artikel
405 Prediction of facial nerve position in large vestibular schwannomas using diffusion tensor imaging (DTI) tractography and its intra-operative correlation Borkar, S.
2017
72 S1 p. S45
artikel
406 Prediction of numbers of melanoma deaths by 2050 Autier, P.
2017
72 S1 p. S123-S124
artikel
407 Predictive factors for recurrence following neoadjuvant chemotherapy and definitive surgery for stage II and III breast cancer: A retrospective review Feroza, Z.
2017
72 S1 p. S37-S38
artikel
408 Predictive factors of late-onset rectal mucosal changes after radiotherapy of prostate cancer Ippolito, E.
2017
72 S1 p. S193
artikel
409 Predictive value of baseline hematology parameters on outcome of 177Lu-DOTATOC-PRRT Kluge, A.
2017
72 S1 p. S151
artikel
410 Predictive value of [18F]FDG PET/CT in patients affected by rectal cancer: correlation with tumour characteristics, treatment response and survival Deantonio, L.
2017
72 S1 p. S60
artikel
411 Predictors of Miller’s pathologic response after induction chemotherapy for advanced female breast cancer; NCI experience Rahouma, M.
2017
72 S1 p. S43-S44
artikel
412 Preferences of women in deciding on treatment for low-grade ductal carcinoma in situ (DCIS) Retel, V.
2017
72 S1 p. S34
artikel
413 Preliminary clinical results of a metabolism-based method to detect circulating tumor cells Del Ben, F.
2017
72 S1 p. S150
artikel
414 Premedication for prophylaxis of hypersensitivity reactions (HSR) after weekly or 3-weekly paclitaxel (ptx): a comprehensive literature review Dewaele, E.
2017
72 S1 p. S165
artikel
415 Preoperative assessment of operability in pancreatic and periampullary carcinoma based on multislice computed tomography and endoscopic ultrasonography Verma, N.
2017
72 S1 p. S78
artikel
416 Preoperative hyperfractionated concurent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study Idasiak, A.
2017
72 S1 p. S51
artikel
417 Preparation of cytological effusion samples by the "plasma-thromboplastin" method and its application detecting malignancy and neoplastic primary site Siqueira, R. Vieira Martins de
2017
72 S1 p. S149
artikel
418 Pressurized IntraPeritoneal Aerosole Chemotherapy (PIPAC) for unresectable peritoneal carcinomatosis: The French experience Sgarbura, O.A.
2017
72 S1 p. S65
artikel
419 Prevalence and associated factors of disability pension in Norwegian cervical cancer survivors Kiserud, C.E.
2017
72 S1 p. S172
artikel
420 Prevalence of cancer in Colombia: What kind of methodologies has been used to obtain prevalence? Valencia, O.
2017
72 S1 p. S141
artikel
421 Prevalence of human papillomavirus in saliva of women with HPV genital lesions in Albania Shkurti, E.
2017
72 S1 p. S95
artikel
422 Prevalence of pain after six month of breast cancer surgery Parveen, S.
2017
72 S1 p. S35
artikel
423 Prevention of chemotherapy-induced nausea and vomiting in patients receiving ifosfamide: High dose chemotherapy Talarmin, C.
2017
72 S1 p. S156
artikel
424 Primary mucosal malignant melanoma of ano-rectal and vulvo-vagina: Epidemiology, clinico-pathological and survival characteristics with proposal for reconciliation of the tumor staging Dev, K.
2017
72 S1 p. S125
artikel
425 Prioritization of lines of hormonal treatment and its impact on patient outcomes and resources for metastatic breast cancer Abotaleb, A.
2017
72 S1 p. S116-S117
artikel
426 Profile of lung cancer in a developing country: single centre experience Gogia, P.
2017
72 S1 p. S178-S179
artikel
427 Prognostic factors in germ cell cancer – a population based study Câmara, G.
2017
72 S1 p. S189
artikel
428 Prognostic impact of nodal relapse in definitive prostate-only irradiation Loi, M.
2017
72 S1 p. S192-S193
artikel
429 Prognostic impact of preoperative serum CA 19-9 level in pancreatic cancer: a pooled analysis Mattiucci, G.C.
2017
72 S1 p. S78
artikel
430 Prognostic impact of primary tumor SUVmax on preoperative 18F FDG-PET/CT in local advanced cervical cancer Cima, S.
2017
72 S1 p. S92
artikel
431 Prognostic value of 18F-fluorodeoxyglucose positron emission tomography (FDG PET) before and during radiotherapy of head and neck cancer Kim, S.
2017
72 S1 p. S108-S109
artikel
432 Prognostic value of pre-operative neutrophil–lymphocyte ratio in predicting patient survival in lower gastrointestinal malignancy Waldron, R.
2017
72 S1 p. S66
artikel
433 Proliferative markers in predicting recurrence risk of breast cancer Bulbul, A.
2017
72 S1 p. S17
artikel
434 Promising alternative for classic randomized controlled trials: first experience with the cohort multiple randomized controlled trial design in the oncologic setting Gregorowitsch, M.
2017
72 S1 p. S9
artikel
435 Prophylaxis and therapy of tumor lysis syndrome in 115 pediatric patients diagnosed with hematological neoplasms Astigarraga, I.
2017
72 S1 p. S147
artikel
436 Prospective evaluation of the impact of multidisciplinary meetings on the decision making process in gastro-intestinal oncology Liberale, G.
2017
72 S1 p. S53
artikel
437 Prospective study on total robotic three stage esophagectomy for esophageal cancer – a single institute Indian experience Naidu, N.
2017
72 S1 p. S82-S83
artikel
438 Psychological assessment following brachytherapy treatment after hysterectomy. From "acceptable" chronic toxicity of physician to the requirements of support of the patients Piro, F.
2017
72 S1 p. S163-S164
artikel
439 Quality of life in elderly patients with breast cancer after mastectomy evaluated using the short form of the Medical Outcomes Study questionnaire (MOS-SF-36) Lumachi, F.
2017
72 S1 p. S17
artikel
440 Quality of life in head and neck cancer survivors treated with radiotherapy Matías-Pérez, A.
2017
72 S1 p. S174-S175
artikel
441 Quality of life in patients with advanced epithelian ovarian cancer after cytoreductive surgery and intraoperative hypertermic intraperitoneal chemotherapy Giulii Capponi, M.
2017
72 S1 p. S92
artikel
442 Quality of life (QL) of muscle invasive bladder cancer (MIBC) patients (pts) receiving radiotherapy (RT) +/- chemotherapy (CT) in the BC2001 trial (CRUK/01/004) Huddart, R.
2017
72 S1 p. S186-S187
artikel
443 Quality of life versus length of life in cancer patients: literature review Shrestha, A.
2017
72 S1 p. S165
artikel
444 Quantifying the transition from active surveillance to watchful waiting in men with very low-risk prostate cancer Van Hemelrijck, M.
2017
72 S1 p. S188
artikel
445 Radiation pneumonitis in patients with esophageal cancer after intensity modulated radiotherapy – incidence and correlation with DVH parameters Tonison, J.
2017
72 S1 p. S81-S82
artikel
446 Radiation-related lymphopenia association with worse prognosis in unresectable hepatocellular carcinoma patients Zhao, Q.
2017
72 S1 p. S81
artikel
447 Radiological differential diagnosis between fibrosis and recurrence after SBRT in early stage NSCLC Frakulli, R.
2017
72 S1 p. S182
artikel
448 Radiomics signature of primary diffusion MR for treatment response prediction in rectal carcinoma Van Griethuysen, J.J.M.
2017
72 S1 p. S58
artikel
449 Randomised phase 3 study of S-1 versus capecitabine, with bevacizumab optional in both arms, in the first-line treatment of metastatic colorectal cancer (mCRC), the SALTO study of the Dutch Colorectal Cancer Group Kwakman, J.J.M.
2017
72 S1 p. S5
artikel
450 Rapid single-cell copy-number aberration analysis using high-throughput sequencing Graier, T.
2017
72 S1 p. S24
artikel
451 Real-world treatment for malignant pleural mesothelioma: the Belgian experience Rosskamp, M.
2017
72 S1 p. S177-S178
artikel
452 Real-world treatment patterns, adverse events (AEs) and outcomes associated with Bacillus Calmette-Guerin (BCG) use for non-muscle invasive bladder cancer (NMIBC) in the United States Malangone-Monaco, E.
2017
72 S1 p. S191
artikel
453 Reassessing, revisiting and redoing incomplete lymph nodal clearance in colon cancer: our experience Roy, B.
2017
72 S1 p. S67
artikel
454 Recognising European Cancer Nursing (RECaN): A systematic review of trial evidence that helps to identify the roles and interventions of nurses caring for patients with cancer Wells, M.
2017
72 S1 p. S4
artikel
455 Recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC): What about second-line chemotherapy combining cetuximab and platinum-doublet after EXTREME protocol? Regnier-Gavier, O.
2017
72 S1 p. S113
artikel
456 Rehabilitation across sectors – a training program Christensen, H.G.
2017
72 S1 p. S168
artikel
457 Relevance of pVHL expression in biological profile of renal cell carcinomas Singhai, A.
2017
72 S1 p. S190
artikel
458 Reporting of outcomes in gastric cancer surgery trials: a systematic review Alkhaffaf, B.
2017
72 S1 p. S134
artikel
459 Response and toxicity after repeat isolated limb perfusion (re-ILP) of in-transit melanoma metastases Olofsson Bagge, R.
2017
72 S1 p. S126
artikel
460 Results of radical chemoradiotherapy for oesophageal and junctional cancers: The Royal Marsden Hospital experience Bernier, L.
2017
72 S1 p. S82
artikel
461 Results of total mesorectal excision with water-jet dissection in patients with rectal cancer Sidorov, D.
2017
72 S1 p. S64
artikel
462 Results of treatment of patients with ovarian cancer initial stage Mamarasulova, D.
2017
72 S1 p. S94
artikel
463 Rethinking exercise identity – a qualitative study among sedentary cancer patients Adamsen, L.
2017
72 S1 p. S166-S167
artikel
464 Retinoblastoma – pattern, presentation and management – a quintessential experience of 5 years Yalavarthy, A.K.
2017
72 S1 p. S145
artikel
465 Retrospective analysis of bevacizumab use in combination with irinotecan for recurrent glioblastoma: a single-institution experience Besson, C.
2017
72 S1 p. S48
artikel
466 Retrospective analysis of definitive chemoradiotherapy with either high-dose or weekly cisplatin in patients with locally advanced squamous cell head and neck cancer: 2-year outcome Van Marcke, C.
2017
72 S1 p. S106
artikel
467 Retrospective analysis of radium-223 treatment for adults with progressive castration-resistant metastatic prostate cancer with symptomatic bone metastasis Gaffney, J.
2017
72 S1 p. S194
artikel
468 Retrospective study of modified video-endoscopic versus open inguinal lymphadenectomy Gurawalia, J.
2017
72 S1 p. S195
artikel
469 Retrospective study of rare cutaneous malignant adnexal tumors of head and neck in a tertiary care cancer hospital Faisal, M.
2017
72 S1 p. S104-S105
artikel
470 Reversal of Hartmann’s procedure, experience in an Asian population Ijaz Ashraf, I.
2017
72 S1 p. S61
artikel
471 Revisiting omental transposition in locally advanced and locally recurrent breast cancer Denariyakoon, S.
2017
72 S1 p. S35
artikel
472 RIZ1 gene promoter hypermethylation is responsible for downregulation of its expression with progression of chronic myeloid leukaemia to advanced phases Bhat, M.A.
2017
72 S1 p. S99
artikel
473 Role of FOBT in Assessment of Colorectal Tumor (FACT study) Jayant, K.
2017
72 S1 p. S156
artikel
474 Role of glossopharyngeal nerve block in palliation of pain from head and neck cancer Panwar, V.
2017
72 S1 p. S46
artikel
475 Role of lateral lymph node dissection in improving survival in low rectal cancer. A single institute, prospective study Dev, K.
2017
72 S1 p. S65
artikel
476 Role of patient organizations in the fight against cancer – Mamma HELP, its projects, activities and experiences Burianova, J.
2017
72 S1 p. S39
artikel
477 Role of PET CT in detection of primary in carcinoma of unknown origin Sharma, A.
2017
72 S1 p. S18
artikel
478 Roles of CD44 and CD24 in predicting response to neoadjuvant chemotherapy Horiguchi, K.
2017
72 S1 p. S44-S45
artikel
479 Safety and effectiveness of anti-HER2 therapy in patients with advanced metastatic tissue HER2-negative breast cancer with elevated serum HER2 and/or HER2 overexpressing circulating tumor cells Kurbacher, C.M.
2017
72 S1 p. S40
artikel
480 Safety and tolerability of nivolumab in an inner city minority population compared to clinical trials data Poola, H.
2017
72 S1 p. S185
artikel
481 Safety of bevacizumab versus no-bevacizumab treatment used on metastatic colorectal cancer: a systematic review and metanalysis Silva, W.C.
2017
72 S1 p. S54-S55
artikel
482 Sarcoma care pathways – the patient viewpoint Wilson, R.
2017
72 S1 p. S6
artikel
483 Sarcoma in irradiated area (SARI): radiation-induced CD8 T-lymphocytes apoptosis as a potential predisposition factor: results of the SARI trial Maingon, P.
2017
72 S1 p. S153-S154
artikel
484 Sarcopenia outperforms the Charlson Comorbidity Index in risk prediction in patients undergoing pancreatic resections Wagner, D.
2017
72 S1 p. S73
artikel
485 Screening of families with hereditary susceptibility to cancer of female reproductive organs Tripac, I.
2017
72 S1 p. S156
artikel
486 Second-line afatinib vs erlotinib for patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8 [LL8]): analysis of tumour and serum biomarkers and long-term responders Gadgeel, S.M.
2017
72 S1 p. S185
artikel
487 Sensor-controlled scalp cooling in the clinical routine: an effective and safe method to prevent chemotherapy-induced alopecia in women with breast or female genital tract cancer Kurbacher, C.M.
2017
72 S1 p. S167-S168
artikel
488 Serial blood draws in metastatic breast cancer patients undergoing systemic treatment analysed by size based CTC detection and mFAST Seq cell free DNA analysis Suppan, C.
2017
72 S1 p. S39-S40
artikel
489 Serum CA19-9 as a tumor marker in patients with endometrial cancer Hashiguchi, Y.
2017
72 S1 p. S88
artikel
490 Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma Tilgen Yasasever, C.
2017
72 S1 p. S125-S126
artikel
491 Serum tumor markers carcinoma antigen (CA) 72–4 versus carcinoembryonic antigen (CEA) in patients with early stage (IA–IB) gastric cancer Lumachi, F.
2017
72 S1 p. S74
artikel
492 Setting international standards in analyzing patient-reported outcomes and quality of life endpoints data for cancer clinical trials (SISAQOL consortium) Pe, M.
2017
72 S1 p. S138
artikel
493 Severe fatigue in adolescent and young adult (AYA) cancer patients: prevalence, impact on quality of life (QOL), and associated factors Poort, H.
2017
72 S1 p. S171
artikel
494 Sex differences in malignant pleural mesothelioma; National Cancer Institute (NCI) experience Rahouma, M.
2017
72 S1 p. S180
artikel
495 SHARP hypofractionated stereotactic radiotherapy is low and intermediate-risk prostate carcinoma patients – PSA outcome Rucinska, M.
2017
72 S1 p. S193-S194
artikel
496 Short-term outcomes of laparoscopic distal gastrectomy (D2+CME) for obese patients with advanced gastric cancer Xie, D.
2017
72 S1 p. S84
artikel
497 Should the Republic of Ireland introduce a national prostate-specific antigen testing programme for the secondary detection of prostate cancer? Results from a population-based cost-effectiveness analysis Burns, R.
2017
72 S1 p. S117
artikel
498 Simultaneous, but not consecutive combination with folinate salts potentiates 5-fluorouracil antitumor activity in vitro Di Paolo, A.
2017
72 S1 p. S68
artikel
499 Single dose or multifractionated reirradiation for painful bone metastasis Kozma, E.
2017
72 S1 p. S162
artikel
500 siRNA-mediated silencing of Snail-1 induces apoptosis and alters microRNA expression in human urinary bladder cancer cell line Mousavi Shenas, M.H.
2017
72 S1 p. S198
artikel
501 Sixteen months follow-up of health related quality of life in women with high-risk breast cancer after random assignment to adjuvant treatment with tailored dose-dense chemotherapy vs standard three-weekly adjuvant chemotherapy (PANTHER study) Brandberg, Y.
2017
72 S1 p. S3
artikel
502 Small renal mass biopsies: An effective tool in avoiding unnecessary surgery McPhee, A.
2017
72 S1 p. S189-S190
artikel
503 SNPS in microRNAs associated with methotrexate plasma levels in Spanish children with acute lymphoblastic leukemia Umerez, M.
2017
72 S1 p. S143
artikel
504 Solid pseudo-papillary tumor of the pancreas: a single centre experience Gupta, N.
2017
72 S1 p. S83-S84
artikel
505 Specialties in pathomorphology of moderately differentiated urothelial tumors of upper urinary tract Ishchenko, K.
2017
72 S1 p. S188
artikel
506 Sphingosine-1-phosphate, sphingosine-1-phosphate receptors (S1P1/S1P3) and cell behaviors in breast cancer cells Çaliş, I.U.
2017
72 S1 p. S19
artikel
507 State of the nutritional management of patients with cancer: a prospective study Houda, A.
2017
72 S1 p. S169
artikel
508 Status of vaccination for cervical cancer in India Kaushik, R.
2017
72 S1 p. S90
artikel
509 Stereotactic body radiotherapy for medically inoperable early stage non small cell lung cancer: a retrospective single-center experience Frakulli, R.
2017
72 S1 p. S183
artikel
510 Stereotactic re-irradiation for recurrent head and neck cancer: predictive factors of efficacy from a single-institution experience Bonomo, P.
2017
72 S1 p. S109-S110
artikel
511 Study of the basic balance of cytokines in the blood of ovarian cancer patients Kurbanov, B.
2017
72 S1 p. S91
artikel
512 Study of the breast dose coverage using auto-flash margin option in Monaco Sanchez Mazon, J.
2017
72 S1 p. S29
artikel
513 Subgroup analysis of leiomyosarcoma patients from a phase 3, open-label, randomized study of eribulin versus dacarbazine in patients with advanced liposarcoma or leiomyosarcoma Blay, J.Y.
2017
72 S1 p. S155
artikel
514 Surgical management of invasive and metastatic thyroid cancer Kaprin, A.
2017
72 S1 p. S111
artikel
515 Surgical management of papillary thyroid carcinoma according to BRAF mutation Polyakov, A.
2017
72 S1 p. S110-S111
artikel
516 Surgical outcome of microsurgical excision of brain and spinal cord cavernomas: Our 13 year single center experience Sawarkar, D.
2017
72 S1 p. S47
artikel
517 Surgical tactics in urethra resection for retroperitoneal tumors Ulmasov, F.
2017
72 S1 p. S85
artikel
518 Surgicopathological quality control in the CRITICS gastric cancer trial Claassen, Y.H.M.
2017
72 S1 p. S7
artikel
519 Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: a nationwide population-based study Rovers, K.
2017
72 S1 p. S7
artikel
520 Survival outcomes in Egyptian elderly patients with breast cancer: single institute experience Gado, N.
2017
72 S1 p. S10
artikel
521 Survival rate of cervical cancer: a five year review at the National Center for Radiotherapy and Nuclear Medicine, Korle-Bu Teaching Hospital, Accra, Ghana Adusei-Poku, P.
2017
72 S1 p. S172
artikel
522 Systematic registration of outcome in a radiotherapy institute Boersma, L.
2017
72 S1 p. S139
artikel
523 Systematic review: Is there any evidence for utilisation of super-selective intra-arterial (IA) chemoradiotherapy in external auditory canal (EAC) tumours over conventional therapy? Gurdial Singh, K.K.
2017
72 S1 p. S108
artikel
524 Systemic therapy as adjunct to cytoreductive surgery with HIPEC for peritoneal metastases of colorectal cancer: a systematic review Rovers, K.
2017
72 S1 p. S69
artikel
525 Targeting of NaV1.5 channel in metastatic breast cancer models in vitro and in vivo mice as a novel therapy Erdogan, M.A.
2017
72 S1 p. S43
artikel
526 Targeting SHP-1–STAT3 signaling: a promising therapeutic approach for the treatment of cholangiocarcinoma Hu, M.H.
2017
72 S1 p. S86
artikel
527 Telfairia occidentalis seed extract protects against oxidative stress, inflammation and some haematological disorders associated with atrazine-induced prostate cancer in rats Adedosu, O.
2017
72 S1 p. S94
artikel
528 The biological role of AKT serine/threonine kinase 2 in lung cancer Serilmez, M.
2017
72 S1 p. S138
artikel
529 The clinical significance of osteopontin (OPN) in non-small cell lung cancer and its biological impact on lung cancer cells Hao, C.
2017
72 S1 p. S182
artikel
530 The close relationship between heparanase and epithelial mesenchymal transition related fibrosis in gastric signet-ring cell adenocarcinoma Shah, S.
2017
72 S1 p. S79
artikel
531 The correlation between FDG-PET parameters and hematologic parameters in patients with esophageal squamous-cell carcinoma treated with definitive chemoradiotherapy Akkus Yildirim, B.
2017
72 S1 p. S80-S81
artikel
532 The effect of nutritional aspects of life style on gastrointestinal cancer Yari Boroujeni, R.
2017
72 S1 p. S158
artikel
533 The efficacy and tolerability of eribulin for advanced or metastatic breast cancer − a case series from the Norfolk and Norwich University Hospital NHS Foundation Trust, United Kingdom Maskell, D.
2017
72 S1 p. S40
artikel
534 The epidemiological study of upper gastrointestinal cancer screening in rural areas in Sichuan, China Song, Z.
2017
72 S1 p. S74-S75
artikel
535 The expression of prolactin receptor and its ligands in ovarian epithelial tumours Magdy, N.
2017
72 S1 p. S89
artikel
536 The financial burden of cancer treatment in a state university hospital in Turkey Unal, E.
2017
72 S1 p. S118-S119
artikel
537 The GASTROS study: standardising outcome reporting in gastric cancer surgery research Alkhaffaf, B.
2017
72 S1 p. S134
artikel
538 The impact of anaemia on survival in gastro-oesophageal cancer Seyed-Safi, P.
2017
72 S1 p. S85
artikel
539 The impact of an automated, telephone-based coaching module on the adoption of an exercise program for cancer chemotherapy patients experiencing symptoms Mooney, K.
2017
72 S1 p. S160
artikel
540 The impact of histological subtype on the prognosis of oesophageal adenocarcinoma Van der Kaaij, R.T.
2017
72 S1 p. S75
artikel
541 The impact of hormone therapy on setup errors during external beam radiation therapy for prostate cancer Onal, C.
2017
72 S1 p. S193
artikel
542 The impact of unplanned surgery and adherence to practice guidelines on outcomes of patients with osteosarcoma Lugowska, I.
2017
72 S1 p. S154
artikel
543 The importance of prognostic nutritional index in cervical cancer patients treated with concomitant chemoradiotherapy Akkus Yildirim, C.
2017
72 S1 p. S93
artikel
544 The incidence of occult level VI lymp node metastasis in cN0 thyroid papillary carcinoma Ozpek, A.
2017
72 S1 p. S111-S112
artikel
545 The International Watch and Wait Database (IWWD) for rectal cancer, an update Van der Valk, M.
2017
72 S1 p. S55-S56
artikel
546 The nephron sparing surgery in localized renal tumor Cuni, X.
2017
72 S1 p. S194
artikel
547 The numbers of Foxp3 positive cells in simultaneous bilateral ER-positive and HER2-negative breast cancer Goto, R.
2017
72 S1 p. S20-S21
artikel
548 The prognostic impact of the pathological response to neoadjuvant dose-dense therapy for ovarian carcinoma Takahiro, E.
2017
72 S1 p. S94-S95
artikel
549 The prognostic value of the comprehensive geriatric assessment (CGA) in elderly cancer patients (ECP) treated with chemotherapy (CT): a systematic review Janssens, K.
2017
72 S1 p. S164-S165
artikel
550 The Prospective Dutch ColoRectal Cancer cohort (PLCRC) − a prospective nationwide observational cohort study Vink, G.
2017
72 S1 p. S55
artikel
551 The rate of incidental papillary microcarcinomas in total thyroidectomy specimens of patients with presumably benign thyroid disease: experience of a university hospital clinic Unal, E.
2017
72 S1 p. S112
artikel
552 The reporting of confounding variables in gastric cancer surgery trials Lo, C.
2017
72 S1 p. S137-S138
artikel
553 The results of neoadjuvant chemoradiation therapy in combined treatment of rectal cancer Abdujapparov, A.
2017
72 S1 p. S50
artikel
554 The RGCIRC Biorepository: accelerating cancer research to seek tomorrow’s cure Yadav, B.K.
2017
72 S1 p. S135
artikel
555 The role of multidisciplinary team discussions in clinical practice: a population-based assessment of rectal cancer patients in Catalonia Manchon-Walsh, P.
2017
72 S1 p. S51-S52
artikel
556 The role of p53 gene suppressor and bcl-2 oncoprotein in non-epithelial ovarian tumor prognosis determination among child and adolescent patients Shukullaev, A.
2017
72 S1 p. S94
artikel
557 The role of post-mastectomy radiotherapy (PMRT) and prognostic factors of locoregional recurrence Delishaj, D.
2017
72 S1 p. S28
artikel
558 The role of topoisomerase II-α (TOPO IIA) as a predictive factor for response to neoadjuvant anthracyclines based chemotherapy in locally advanced breast cancer Gamea, M.
2017
72 S1 p. S37
artikel
559 The role of volunteers in quality palliative care delivery Manna, A.
2017
72 S1 p. S160-S161
artikel
560 The safety and efficacy of bleomycin, etoposide and cisplatin (BEP) chemotherapy in patients with malignant ovarian germ cell tumor Lee, G.
2017
72 S1 p. S96
artikel
561 The shift from delayed radiotherapy to localized radiotherapy strategy in treatment of infantile medulloblastoma – challenging experience from LMIC Ahmed, S.A.
2017
72 S1 p. S146
artikel
562 The spine instability neoplastic score (SINS) in the assessment of response to radiotherapy for bone metastases Gallizia, E.
2017
72 S1 p. S161
artikel
563 The state of cancer care for cancer of the uterine body and the ways of its improvement in the Republic of North Ossetia-Alania in 1990–2014 Bosieva, A.
2017
72 S1 p. S97
artikel
564 The state of cancer care in breast cancer in women and the ways of its improvement in the Republic of North-Ossetia Alania in 1990–2014 Bosieva, A.
2017
72 S1 p. S35
artikel
565 The state of cancer care in ovarian cancer and ways of its improvement in the Republic of North Ossetia-Alania in 1990–2014 Bosieva, A.
2017
72 S1 p. S97
artikel
566 The therapeutic possibility of intrathecal administration of trastuzumab for the carcinomatous meningitis of HER2-positive metastatic breast cancer: the low penetration of trastuzumab into the cerebrospinal fluid via intravenous administration Honda, Y.
2017
72 S1 p. S20
artikel
567 The treatment of acute and late vaginal toxicity after adjuvant high dose rate [HDR] vaginal brachytherapy in patients with intermediate risk endometrial cancer: Is local therapy with hyaluronic acid of clinical benefit? Laliscia, C.
2017
72 S1 p. S92-S93
artikel
568 The use of an interactive cartoon web page to support communication between parents with cancer and their children Vestergaard, L.V.
2017
72 S1 p. S168-S169
artikel
569 The use of olanzapine compared to aprepitant as antiemetic for prevention of chemotherapy induced nausea and vomiting in highly emetogenic chemotherapy – a randomized trial Sapkota, S.
2017
72 S1 p. S168
artikel
570 Three year follow-up data after RePCa – a randomised rehabilitation study among radiated prostate cancer patients Dieperink, K.B.
2017
72 S1 p. S174
artikel
571 To evaluate P-glycoprotein expression in relation to molecular subtypes and predicting response to neoadjuvant chemotherapy in breast cancer – a study from a tertiary care center in India Mehrotra, M.
2017
72 S1 p. S23
artikel
572 Tolerability and efficacy of rolapitant for prevention of chemotherapy induced nausea and vomiting: a systematic review and meta-analysis of active-controlled trials Ahmed, H.
2017
72 S1 p. S140
artikel
573 Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients Kwakman, R.J.
2017
72 S1 p. S69
artikel
574 Tongue flap reconstruction for defects after resection of oral cancer: a versatile flap Pawar, S.S.
2017
72 S1 p. S112
artikel
575 Total preoperative NACT vs sandwich NACT in breast cancer patients: systematic review and meta-analysis Pathak, M.
2017
72 S1 p. S43
artikel
576 Translation and validation of PREM-questionnaire Tolstrup, L.
2017
72 S1 p. S139
artikel
577 Translation initiation separates low and high grade colon and rectum carcinoma Golob-Schwarzl, N.
2017
72 S1 p. S57
artikel
578 Transmural care for glioma patients and their family caregivers: utility and feasibility as perceived by professional caregivers Decadt, I.
2017
72 S1 p. S131
artikel
579 Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: a single-centre experience Kingston, C.
2017
72 S1 p. S14
artikel
580 Treatment compliance and outcome in geriatric patients with locally advanced non-small cell lung cancer: Experience from India Pathy, S.
2017
72 S1 p. S183
artikel
581 Treatment patterns and clinical outcomes in ER+/HER2- metastatic breast cancer in German real world settings Mitra, D.
2017
72 S1 p. S141
artikel
582 Treatment with eribulin mesilate could suppress epithelial– mesenchymal transition (EMT) in tumors of patients with metastatic breast cancer – preliminary report of a prospective study Utsumi, T.
2017
72 S1 p. S39
artikel
583 Triple negative breast cancer in Indian population: An analysis from a tertiary cancer center in India Paryani, J.
2017
72 S1 p. S12-S13
artikel
584 Tumor circulating microemboli as poor prognosis factor in patients with locally advanced head and neck squamous cell carcinoma under treatment Fanelli, M.
2017
72 S1 p. S105
artikel
585 Tumor hypoxia in colorectal cancer evaluated by 18F-fluoromisonidazol PET/CT Olarte, M.
2017
72 S1 p. S56
artikel
586 Tumor markers in the diagnosis and monitoring of breast cancer (BC) Mamarasulova, D.
2017
72 S1 p. S87
artikel
587 Tumour infiltrating (TINK) and Tumour associated (TANK) natural killer cells: novel inflammatory orchestrators in colorectal cancer (CRC) progression and angiogenesis Albini, A.
2017
72 S1 p. S59
artikel
588 Two countries − two treatment strategies for rectal cancer Guren, M.
2017
72 S1 p. S49
artikel
589 Two year overall survival rate of all advanced melanoma patients treated with ipilimumab in Australia 2013–2014 Kim, H.
2017
72 S1 p. S4
artikel
590 Types and patterns of gastrointestinal (GI) polyps encountered in oesophago-gastro-duodenoscopy at a tertiary care center Wickramasinghe, D.
2017
72 S1 p. S74
artikel
591 Ultraviolet irradiation for medical reasons and deadly melanoma Autier, P.
2017
72 S1 p. S126
artikel
592 Understanding prostate cancer biology using metabolomics and proteomics approaches: potentials in the improvement of the diagnosis, prognosis and identification of new therapeutic targets Felgueiras, J.
2017
72 S1 p. S192
artikel
593 Understanding unwarranted variations of use of high-cost cancer drugs: a Comprehensive Cancer Care Network approach De Giorgi, U.
2017
72 S1 p. S114-S115
artikel
594 Unexplained rises in UK cancer drug prices between 2011 and 2016 Hill, A.
2017
72 S1 p. S113-S114
artikel
595 Unique gene expression signature of cancer initiating cells in colorectal cancer Manhas, J.
2017
72 S1 p. S57
artikel
596 Updated prognostic models for local recurrence, distant metastases and overall survival in a pooled dataset of 3770 rectal cancer patients Masciocchi, C.
2017
72 S1 p. S59
artikel
597 Update of the international prognostic classification for first line metastatic germ-cell cancers. An international initiative Collette, L.
2017
72 S1 p. S196-S197
artikel
598 Upregulation of MicroRNA-1182 activates the apoptotic pathway p38/MAPK in MDA-MB-435 melanoma cells following reprogramming with transcription factors Oct3/4, Klf-4, Sox-2, c-Myc Kutlu, K.
2017
72 S1 p. S150
artikel
599 Usefulness of pre-operative axillary ultrasound investigation, ultrasound-guided fine-needle aspiration biopsy and/or intraoperative imprint cytological investigation in patients undergoing mastectomy because of invasive lobular breast carcinoma Novak, J.
2017
72 S1 p. S31
artikel
600 Use of Cochrane evidence in supporting medical policies of oncology drugs in the United States Hussain, S.
2017
72 S1 p. S120
artikel
601 Use of diffusion weighted-MRI (DW-MRI) as a prognostic biomarker of survival and time to cystectomy in muscle invasive bladder cancer (MIBC) following organ conserving treatment Hafeez, S.
2017
72 S1 p. S192
artikel
602 Use of lidocaine 5% patches in post-thoracotomy and post-mastectomy cancer pain Moda, N.
2017
72 S1 p. S168
artikel
603 Uterine motion associated with strict bladder filling protocol during image-guided radiotherapy (IGRT) of carcinoma cervix – do we need to redefine internal target volume (ITV) margins? Mukherjee, A.
2017
72 S1 p. S93
artikel
604 Vaccine targeting HIF1A in triple negative breast cancer Ssempala, A.
2017
72 S1 p. S26
artikel
605 Validation of an assessment tool for predicting overall survival following gastric cancer resection Haga, Y.
2017
72 S1 p. S72
artikel
606 Validation of the assessment of cancer-related symptom scale Ohlsson-Nevo, E.
2017
72 S1 p. S165
artikel
607 Value of body mass index, pathological complete response, and residual tumors after complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for patients with recurrent ovarian cancers. Experience from MISR Cancer Center Amira, G.
2017
72 S1 p. S90-S91
artikel
608 Value of innovation in oncology: the policy position of the European Cancer Patient Coalition De Lorenzo, F.
2017
72 S1 p. S121
artikel
609 Value of intra-operative ultrasound in localization of breast masses during breast conserving surgery Moustafa, A.
2017
72 S1 p. S30
artikel
610 Verapamil potentiates temozolomide anticancer efficacy through the intrinsic apoptotic pathway in human glioblastoma cells Hanif, F.
2017
72 S1 p. S47
artikel
611 Vitamin D receptor and calcium sensing receptor polymorphisms and colorectal cancer survival in Newfoundland population Zhu, Y.
2017
72 S1 p. S56
artikel
612 Volume displacement techniques for filling partial mastectomy defects Moustafa, A.
2017
72 S1 p. S30
artikel
613 Ways to improve long-term results of combined treatment of patients with colorectal cancer liver metastases Moiseenko, A.
2017
72 S1 p. S55
artikel
614 We have managed to reduce the time patients spend in hospital by changing cancer nurse’s logistics and workflow routines Solenes, T.
2017
72 S1 p. S133
artikel
615 What are cancer advanced nurse practitioners’ perceptions and experiences of introducing Holistic Needs Assessment (HNA) into clinical practice to address individual cancer patient’s needs? Mitchell, K.
2017
72 S1 p. S175
artikel
616 What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups Petit, C.
2017
72 S1 p. S101-S102
artikel
617 Which one is the best for breast cancer; tamoxifen plus hyperthermia or tamoxifen plus radiotherapy? Joveini, Z.
2017
72 S1 p. S21
artikel
618 Which one is the best for estrogen receptor positive and triple negative breast cancers; hyperthermia before radiotherapy or after? Joveini, Z.
2017
72 S1 p. S21
artikel
619 Whole liver CT texture analysis to predict the development of colorectal liver metastases − a multicentre study Beckers, R.
2017
72 S1 p. S49
artikel
620 Wnt signaling pathway in the diagnosis of papillary thyroid cancer Nascimento dos Santos, J.
2017
72 S1 p. S108
artikel
621 WWOX-deficiency promotes increased survival by enhancing homology-directed repair Batar, B.
2017
72 S1 p. S148-S149
artikel
                             621 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland